WO2013002185A1 - Array and method for detecting target polynucleotide - Google Patents

Array and method for detecting target polynucleotide Download PDF

Info

Publication number
WO2013002185A1
WO2013002185A1 PCT/JP2012/066167 JP2012066167W WO2013002185A1 WO 2013002185 A1 WO2013002185 A1 WO 2013002185A1 JP 2012066167 W JP2012066167 W JP 2012066167W WO 2013002185 A1 WO2013002185 A1 WO 2013002185A1
Authority
WO
WIPO (PCT)
Prior art keywords
array
detection method
detection
hybridization
less
Prior art date
Application number
PCT/JP2012/066167
Other languages
French (fr)
Japanese (ja)
Inventor
定彦 鈴木
千絵 中島
晴香 鈴木
英正 奥村
三雄 川瀬
廣田 寿一
孝介 丹羽
Original Assignee
国立大学法人北海道大学
日本碍子株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立大学法人北海道大学, 日本碍子株式会社 filed Critical 国立大学法人北海道大学
Publication of WO2013002185A1 publication Critical patent/WO2013002185A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Definitions

  • the present specification relates to a method for detecting a target polynucleotide, an array therefor, and the like. (Refer to related applications) This application claims priority based on Japanese Patent Application No. 2011-143441, filed on June 28, 2011, the contents of which are incorporated herein by reference.
  • tests such as identifying a living body by targeting a specific nucleotide or base sequence in a gene of a biological sample have been performed.
  • a gene region required for each type of Mycobacterium tuberculosis is amplified by a PCR method, and the amplification product is hybridized with an oligonucleotide probe fixed on a membrane, thereby testing the strain type.
  • this type of method for example, there is a method using a membrane in which dozens of specific probes necessary for each type of bacteria to be detected are prepared and these probes are immobilized in a parallel line pattern.
  • a PCR product prepared from a sample is supplied and hybridized using a blotter so as to be perpendicular to the line pattern of these probes. Kits for carrying out this method are also commercially available.
  • the membrane after hybridization is incubated with peroxidase-labeled streptavidin.
  • the hybridized PCR product is labeled with peroxidase, and the chemiluminescence signal from the ECL reagent is exposed to the X-ray film.
  • the type can be determined based on the sequence pattern of the specific probe expressed according to the type of bacteria contained in the biological sample.
  • Patent Document 1 In order to facilitate the detection of the target polynucleotide, two or more types of physiologically active substances are fixed on a test paper or the like, and the physiologically active substances are adjacent to each other so that a physiological complex reaction can be easily detected visually. It is also being studied (Patent Document 1). In addition, it has been attempted to easily identify the position of a nucleic acid probe bound to a target substance by spotting a fluorescently labeled reagent or the like around the spot where the nucleic acid probe is spotted (Patent Document 2). .
  • the above-described typical commercial kit is a method of performing hybridization using a blotter, and therefore, several tens of kinds of probes are immobilized on a large (14 cm square) membrane, and a sample is also prepared at a time. Although several tens of samples can be hybridized, even when the number of samples was small, the same amount of reagent was used and the same treatment had to be performed. In addition, due to such circumstances, it is difficult to test each specimen.
  • Patent Document 1 discloses a test piece (60 to 300 mm 2 ) having a relatively small area, but does not meet individual and prompt requests for each specimen. Furthermore, since Patent Document 2 requires a large amount of a fluorescent material such as Cy5 and a dedicated scanner, the cost increases.
  • an object of the present specification is to provide a more practical method for detecting a target polynucleotide and an array therefor.
  • the present inventors provide a more practical method for detecting a target polynucleotide, that is, a detection method and an array therefor, which can reduce the number of specimens, and most preferably enable a test to be performed for each specimen. investigated. More specifically, a detection method and an array therefor have been studied that can realize speediness, simplicity, and low cost. As a result, it was found that the reaction system can be made compact and the detection can be visualized with the naked eye. According to the present invention, the following means are provided.
  • a method for detecting a target polynucleotide comprising: Performing hybridization on the test sample and the oligonucleotide probe on the array comprising a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide on a solid phase carrier; and Providing a double-stranded hybridization product obtained by the hybridization with a detection signal that can be visually recognized by the naked eye; Detecting a target polynucleotide based on the detection signal; With The detection method, wherein the hybridization step is a step of performing hybridization in a solution of 1 ml or less for each array using the array.
  • the size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, and the solid phase carrier has a plane area of 150 mm 2 or less and an aspect ratio of 1.5 or more.
  • the detection method according to (1) wherein hybridization is performed using the array that is a sheet-like body.
  • hybridization is performed in a solution of 0.3 ml or less for each array, using the array in which the solid phase carrier is a sheet-like body having a plane area of 50 mm 2 or less.
  • the detection method according to (1) or (2) which is a step.
  • the solid phase carrier is selected from polyethersulfone, nitrocellulose, nylon, polyvinylidene fluoride, and filter paper.
  • the thickness of the solid phase carrier is 0.01 mm or more and 0.3 mm or less.
  • the array includes a handling portion at a predetermined part of an outer edge of the plurality of immobilization regions.
  • the hybridization step and the signal imparting step are performed while maintaining the state in which the array is put in the same tube-shaped container in a predetermined direction.
  • Detection method (14) The detection method according to (13), wherein the detection step is performed while maintaining the state where the array is put into the container with a predetermined direction.
  • the detection step is a step of detecting a plurality of the target polynucleotides based on a combination of detection signals obtained from a predetermined plurality of the immobilized regions. The detection method described.
  • the detection step is a step of detecting the combination in comparison with the coloring pattern of the immobilized region obtained on the array and the coloring pattern sample of the oligonucleotide probe corresponding to the combination.
  • (18) The detection method according to any one of (1) to (17), wherein the number of the immobilized regions is 2 or more and 200 or less.
  • (19) The detection method according to any one of (1) to (18), wherein the oligonucleotide probe is a probe having a base sequence that is an orthonormal sequence.
  • the size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less
  • the solid phase carrier is a sheet-like body having a plane area of 150 mm 2 or less and an aspect ratio of 1.5 or more and 20 or less.
  • An array sheet for detecting a target polynucleotide comprising: Provided with a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide, a color sample region that presents color development by a detection signal visible to the naked eye, and a plurality of array regions on a solid phase carrier And
  • the size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, the array region has a plane area of 150 mm 2 or less, and an aspect ratio of 1.5 or more and 20 or less,
  • the solid phase carrier is a sheet that is separable for each array region.
  • This specification relates to a method for detecting a target polynucleotide, an array for the same, and the like.
  • the detection method disclosed in the present specification can detect a target polynucleotide quickly and easily on a small scale. Reducing the scale of the reaction system can reduce the cost by reducing the amount of the reagent, and by controlling the scale of the array, the temperature can be controlled with high accuracy and speed. Furthermore, the detection by visible light can reduce the cost of the apparatus, and the observation of color development in real time contributes to the speed of inspection.
  • the array and sheet disclosed in the present specification are suitable for such a small-scale reaction, and particularly excellent in applicability to a tubular container of 0.5 ml or less.
  • the target polynucleotide means a polymer of nucleotides, and the number thereof is not particularly limited. Therefore, the target polynucleotide includes an oligonucleotide in which several tens of nucleotides are linked.
  • the target polynucleotide is a base that serves as a genetic index in organisms such as humans and non-human animals, such as constitution, genetic disease, onset of specific diseases such as cancer, disease diagnosis, treatment prognosis, drug and treatment selection, etc. Or the base sequence is included. Typically, polymorphisms such as SNP and congenital or acquired mutations can be mentioned.
  • base sequences derived from microorganisms such as pathogenic bacteria and viruses are also exemplified as base sequences possessed by the target polynucleotide.
  • the detection method disclosed in the present specification includes a hybridization step, a signal imparting step, and a target polynucleotide detection step.
  • the hybridization step prepares an array comprising a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide on a solid phase carrier, and the oligonucleotide probe on the array and the test sample are It can be set as the process of performing the hybridization which implements hybridization in a 1 ml or less solution for every said array.
  • the array of the present invention used in this method will be described first.
  • the array disclosed herein comprises a plurality of immobilized regions of oligonucleotide probes pre-associated with a target polynucleotide on a solid support.
  • this array has a form that allows hybridization in a liquid of 1 ml or less per solution. That is, the solid support of the said form (size and shape) is provided.
  • the form that allows hybridization in a solution of 1 ml or less in the array varies depending on the size of the hybridization container.
  • a tapered or cylindrical tube container is intended as the container. It is preferable. That is, it is preferable to implement this detection method using such a container.
  • An example of the tapered container is typically an Eppendorf tube (trade name), and an example of a cylindrical container is typically a general test tube.
  • the tube-like container preferably has a volume capable of being filled with, for example, 1 ml or less, 0.5 ml or less, and 0.3 ml or less hybridization solution.
  • Such tubular containers each have an inner diameter of 7-9 mm, typically 8 mm, a depth of 37-39 mm, typically 38 mm, an inner diameter of 5-7 mm, typically 6 mm, a depth of 29-31 mm, typically Specifically, those having a size of 30 mm and an inner diameter of 4 to 6 mm, typically 5 mm, a depth of 19 to 21 mm, and typically 20 mm can be mentioned.
  • the container is also preferably transparent. This is because it is convenient to visually check the state of the internal array, and thus the detection signal.
  • the container may be provided with a detachable lid to open and close its opening (usually the upper part). By providing such a lid, it is possible to prevent evaporation of a small amount of liquid and the like and to quickly and easily control the temperature.
  • the form of the array preferably has a plane area of 150 mm 2 or less.
  • the area is less than this plane area, hybridization is possible in the immobilization region even in a solution of 1 ml or less. More preferably, it is 100 mm 2 or less, and further preferably 50 mm 2 or less. When it is 50 mm 2 or less, it is also effective for hybridization in a solution of 0.3 ml or less.
  • the rectangular shape has an aspect ratio of 1.5 or more.
  • Such a square shape is easy to fit in a tubular container and is easy to handle.
  • the shape is rectangular, the directionality of the array can be easily determined visually, which is convenient for the hybridization step, the signal application step, and the detection step.
  • the aspect ratio is 20 or less. This is because when the aspect ratio exceeds 20, it is difficult to grasp the detection pattern of the fixed region. When the aspect ratio is 20 or less, it is easy to visually grasp the signals in the plurality of fixed regions as a pattern. Can be improved.
  • the aspect ratio is preferably 15 or less, more preferably 10 or less, still more preferably 5 or less, and even more preferably 3 or less.
  • the array is preferably in the form of a sheet.
  • it is easy to handle and is advantageous for storage as inspection data.
  • it is easy to impart a certain degree of flexibility, which can advantageously contribute to the filling property, storage property, and reactivity in a small-scale container.
  • the thickness of the array is preferably 0.01 mm or more and 0.3 mm or less as the thickness of the solid phase carrier.
  • the array comprises a plurality of immobilization regions of oligonucleotide probes pre-associated with a target polynucleotide on a solid support.
  • the oligonucleotide probe is appropriately selected according to the object to be detected, the detection technique, or the target polynucleotide detection system. For example, in order to determine the species (type) of an infectious agent such as an infectious disease, detection is performed by hybridization with a plurality of oligonucleotide probes. In detecting a mutation, one or a plurality of oligonucleotide probe immobilization regions may correspond to one mutation.
  • a universal probe that is always a probe having a predetermined base sequence may be used regardless of the base sequence of the target polynucleotide.
  • a universal probe is a base sequence designed by, for example, calculating a continuous match length, melting temperature prediction by the Nearest-Neighbor method, Hamming distance, and secondary structure prediction for a DNA sequence of a predetermined base length obtained from a random number.
  • An orthonormal sequence is a base sequence of nucleic acid having a uniform melting temperature, that is, a sequence designed so that the melting temperature is within a certain range, and the nucleic acid itself is intramolecular.
  • a base sequence that does not form a structure and does not inhibit hybridization with a complementary sequence, and that does not form a stable hybrid other than a complementary base sequence can be meant.
  • a sequence included in one orthonormal sequence group hardly reacts between sequences other than the desired combination and within a self-sequence, or does not generate a reaction.
  • the orthonormal sequence is amplified by PCR or the like, the amount of nucleic acid corresponding to the initial amount of the nucleic acid having the orthonormal sequence is quantitatively determined without being affected by the problem such as the above-described cross-hybridization. Can have the property of being amplified.
  • the orthonormal sequences as described above are described in detail in H. Yoshida and A.Suyama, “Solution to 3-SAT by breadth first search”, DIMACS Vl.54, 9-20 (2000).
  • An orthonormal array can be designed based on these documents.
  • a specific universal probe is associated with the target polynucleotide in advance. Then, the target polynucleotide is subjected to a hybridization reaction with a primer and a ligase reaction, and a ligase specific to the target polynucleotide having a base sequence identical or complementary to the base sequence of the associated universal probe. A product is obtained, and hybridization between the ligase product and the universal probe on the array is performed. The ligase product hybridizes with a pre-associated probe to produce a double stranded hybridized product. For detection of mutation such as SNP, a plurality of universal probes may be assigned to one target polynucleotide. This type of method is carried out with reference to Japanese Patent Application Laid-Open No. 2008-306941, Analytical Biochemistry, 364, 1, 2007, 78-85, as well as JP2009-232778, JP2009-24, etc. can do.
  • one kind of oligonucleotide probe is immobilized.
  • the method for immobilizing the oligonucleotide probe to the solid phase carrier those skilled in the art can appropriately adopt various known methods as necessary.
  • each immobilization region is 0.2 mm 2 or more and 150 mm 2 or less.
  • the thickness is less than 0.2 mm 2 , the visual visibility is excessively lowered, and when it exceeds 150 mm 2 , there is a problem in the size of the array.
  • the shape of the immobilization region is not particularly limited, and may be various known forms applied in the array, such as a circular shape and a rectangular shape. In view of the packing density and visibility of the immobilization region, a rectangular shape is preferable, and a square shape is more preferable.
  • the number of immobilization areas is appropriately set according to the purpose of detection and the use of the detection method. Considering the size of the array and the like, it is not particularly limited, but it is preferably 2 or more and 200 or less. This is because if the number exceeds 200, it may be difficult to determine the size of the array and to visually detect and judge.
  • visual signal detection in one or a plurality of immobilization regions is taken into consideration, it is preferably 150 or less, more preferably 100 or less.
  • the number of immobilization regions is preferably 20 or more, more preferably 40 or more. When it is 20 or more, for example, it is highly versatile in various diagnoses.
  • the plurality of immobilization regions form one compartment on the solid support. It is preferable that the section has an alignment form by a combination of a vertical row and a horizontal row according to the shape of the array. Typically, these compartments are square.
  • the array can be separately provided with a color sample region by a detection signal in addition to a plurality of immobilization regions on a solid phase carrier.
  • the color development sample region is a color development sample of a signal applied in a signal application step described later, and is provided in advance with a color tone, lightness, and saturation corresponding to the signal. That is, it is given so that it can be maintained through the detection method.
  • the color sample area is provided by ink, and pigment ink is preferably used in consideration of fixability to a solid phase carrier and reactivity.
  • Such inks are typically applied to a solid phase carrier in the same manner as when an oligonucleotide probe is applied to a solid phase carrier to form an immobilized region (for example, an inkjet method using a piezo element).
  • the color development sample region is preferably provided on the solid phase carrier in the same size and shape as the immobilization region because of the requirement for comparative observation. Furthermore, it is preferable that the color development sample region is formed adjacent to the immobilization region so that it can be easily compared with the signal in the immobilization region.
  • the color development sample region is preferably composed of two or more types of regions having different degrees of color or shade of the detection signal. With such a configuration, visual signal detection can be performed more easily and reliably. Preferably, at least two color sample regions corresponding to the upper limit and the lower limit of the color tone or shading of the detection signal are provided. By providing such a color sample area, signal detection can be determined using the above upper and lower limits as indices, and easier and more reliable detection is possible regardless of the skill level of the tester and reaction errors.
  • the array can be provided with a handling site outside the compartment consisting of a plurality of immobilization regions.
  • a handling site typically, handling can be ensured even in a small array, the array can be handled in a certain direction, experimental accuracy or detection accuracy can be improved, and signal detection can be facilitated.
  • As the handling site typically, a margin region in which an immobilization region or a color sample region on a solid phase carrier is not formed can be applied.
  • it is convenient to handle the array by providing a handling part on a part of the array, for example, one end (especially one short edge) of the square sheet, and the array can be easily maintained in a certain direction.
  • the handling site can be provided with specimen identification information for individually identifying the array, and such specimen identification information may be previously given to ink or the like.
  • the specimen identification information may be numbers, symbols, characters or figures, or a combination thereof.
  • the array can be equipped with information useful for operation and identification.
  • information useful for operation and identification For example, direction identification information that determines the directionality of the array at the time of operation or detection can be given.
  • the margin area (handling part), color sample area, and specimen identification information described above can also be used as direction identification information.
  • Solid phase carrier The solid phase carrier constituting the array is not particularly limited, but it is preferable to have liquid permeability or permeability in consideration of downsizing, handling on a small scale, reactivity, visibility of detection signal, and the like.
  • liquid permeability or permeability in consideration of downsizing, handling on a small scale, reactivity, visibility of detection signal, and the like.
  • porous membrane filters mainly composed of polymers such as polyethersulfone, nitrocellulose, nylon, and polyvinylidene fluoride, filter paper such as cellulose can be preferably used.
  • hybridization is performed in a solution of 1 ml or less, preferably 0.5 ml or less, more preferably 0.3 ml or less per array.
  • the hybridization step when the test sample contains an oligonucleotide having a target polynucleotide that forms a base pair with the probe, a double-stranded hybridization product is formed.
  • the hybridization step is preferably performed while the array is placed in a tubular container in a predetermined direction and maintained in that state. Specifically, it is preferable to carry out while maintaining a state in which the long side of the array is along the depth direction of the container in accordance with the internal form of the tubular container.
  • the hybridization step when a tube-like container is used, it can be applied to an existing temperature control device for PCR. By performing such temperature control, temperature control can be performed accurately and quickly.
  • the conditions for the hybridization step are not particularly limited. A normal hybridization medium can be used. Moreover, it can set to moderate temperature.
  • washing step it is appropriate to remove the hybridization solution from the container in which the hybridization step has been performed and leave only the array, and then supply a solution suitable for washing under a predetermined temperature condition and contact for a suitable time. This can be done by repeating several times. By carrying out such a cleaning process in the same container, the operation can be simplified, the number of containers can be reduced, and temperature control can be performed quickly and accurately.
  • the test sample to be subjected to the hybridization step is not particularly limited as long as it contains a target polynucleotide that may be a target of hybridization.
  • a test sample known gene information to which probe hybridization is applied, a test sample in a detection, test, or diagnostic method using DNA can be used in this method.
  • Test samples include various biological samples (blood, urine, sputum, tissue, cells (including cultured animal cells, cultured plant cells, cultured microbial cells derived from various animals)) or DNA from such biological samples. Extracted DNA extracted samples, amplified samples by various gene amplification techniques from DNA and RNA of such biological samples are included. In consideration of the signal providing step described later, it is preferable that the oligonucleotide in the test sample is labeled in advance. A person skilled in the art can easily prepare such a test sample based on a well-known technique. For example, the following test sample preparation process may be performed.
  • the method of the present invention may comprise a step of preparing a test sample by a gene amplification reaction using the same container as that used for the hybridization step prior to the hybridization step.
  • the hybridization step can be performed by introducing the array into the container used for amplification.
  • the number of containers to be used can be reduced and the operation can be simplified.
  • the gene amplification reaction various known reactions can be used. Examples include PCR by various methods, LCR, SDA, ICAN, and the like.
  • the polynucleotide in the test sample can be labeled by a method of incorporating dNTP linked with a predetermined label-binding substance.
  • the label-binding substance include haptens (primary signal) such as digokigenin (DIG).
  • DIG digokigenin
  • the hapten-specific recognition antibody can be used, and a chromogenic substance (secondary signal) such as peroxidase imparted to the recognition antibody can be used as a detection signal.
  • a gene amplification reaction solution or a hybridization solution in the same container after the gene amplification reaction. Further, it is more preferable to carry out the denaturation step at a high temperature prior to the hybridization in the same container. By doing so, it is possible to simplify the operation, further speeding up the operation, speeding up the temperature control and increasing the accuracy.
  • the signal imparting step can be a step of imparting a detection signal visible to the naked eye to the double-stranded hybridized product obtained in the hybridization step.
  • a detection signal visible to the naked eye to the double-stranded hybridized product obtained in the hybridization step.
  • a primary signal such as biotin in addition to a hapten is previously given to a polynucleotide in a test sample.
  • a detection signal that can be visually recognized by the naked eye can be given using the secondary signal. That is, an antigen-antibody reaction or a biotin-avidin reaction can be used as a detection system.
  • the secondary signal is preferably an enzyme that produces a chromogenic product. By doing so, it is possible to detect the chromogenic product promptly and in real time using an enzyme reaction.
  • the secondary signal can be a complex comprising an antibody that specifically binds to the hapten and such an enzyme.
  • the secondary signal does not necessarily include such an enzyme, and may simply be an antibody that binds to a primary signal such as a hapten.
  • a complex of a secondary antibody and an enzyme that specifically binds to the antibody that is the secondary signal may be used as the tertiary signal.
  • a well-known technique in ELISA or biotin-avidin system can be used.
  • the signal imparting step is preferably performed in the same container used in the hybridization step. By doing so, the operation can be simplified and the speed can be improved. Further, by leaving the array in the same container, it is possible to easily maintain a certain directionality when the array is put into the container (in the hybridization step).
  • the labeling reaction can be carried out by introducing a solution containing a secondary signal into the same container in which the array after removal of the excess sample remains. Except for the case where the secondary signal can be visually recognized with the naked eye after washing after removing the excessive secondary signal, a color reaction for developing the secondary signal is further performed. For example, when an enzyme such as peroxidase is used as the secondary signal, after removing the excess peroxidase, a substrate is supplied to cause an enzyme reaction. If a tertiary signal is required, additional washing and reaction steps are performed.
  • the detection step can be a step of detecting the target polynucleotide based on the detection signal imparted to the double-stranded hybridization product in the signal imparting step. As described above, since the detection signal is imparted to the double-stranded hybridization product, this is observed with the naked eye to detect the presence or absence of the target polynucleotide.
  • Detecting may be performed in a container filled with the array, or may be performed outside the container after the array is taken out of the container. Moreover, you may carry out in the state in which the liquid for signal provision is thrown in.
  • the same orientation as that used at the time of detection is detected when detecting the detection signal in the array by maintaining the orientation of the array in the same container as that used in the hybridization step. Therefore, the target polynucleotide can be easily detected and the accuracy is high.
  • the array When the array has a color sample area, it is possible to detect the color tone and the contrast in a quick and highly accurate manner by observing the color tone and the contrast.
  • the array when the array includes at least two color development sample regions corresponding to the upper and lower limits of the color tone or shading of the detection signal, it can be a step of detecting the target polynucleotide using the upper limit and the lower limit as an index. . In this way, highly accurate detection is possible without depending on skill level or reaction error.
  • the detection step may be a step of detecting a combination of a plurality of target polynucleotides in the test sample according to the detection target and application.
  • a combination of a plurality of immobilization regions corresponding to a plurality of target polynucleotides is detected.
  • such a combination may be detected by comparing the coloring pattern of the immobilization region obtained on the array with the coloring pattern sample of the oligonucleotide probe corresponding to the combination.
  • Such a color pattern sample is prepared in advance. For example, by preparing for each pattern to be detected, it is possible to quickly and easily determine with high accuracy.
  • the hybridization step and the signal imparting step are preferably performed in the same container, the present invention is not limited to this and may be performed in different containers.
  • the test sample preparation process is the same.
  • an appropriate liquid may be prepared and arranged in different containers in advance for each process or for each finer step, and the array may be moved according to the reaction process.
  • the present invention also provides an array for use in the method of the present invention.
  • the array of the various aspects described above is also included in the present invention.
  • an array sheet including a plurality of such arrays as an array region is also provided. That is, an array sheet for detecting a target polynucleotide, and a plurality of array regions including a plurality of immobilized regions of oligonucleotide probes previously associated with the target polynucleotide are separable for each array region.
  • An individual array sheet is provided. According to this sheet, the array used in the method of the present invention can be easily manufactured and supplied.
  • each array region for example, when the above-described preferred solid support is used, cutting can be performed with a commonly used cutter or scissors.
  • the array region can be easily separated by manual operation by providing a fragile portion that can be cut between the array regions.
  • a DNA probe solution consisting of a base sequence shown in the following table is made on a sheet made of polyethersulfone modified with an aldehyde group and having a size of 285 mm ⁇ 50 mm, a pore diameter of 0.5 ⁇ m, and a thickness of 0.15 ⁇ m. Spotting was performed using a GENSHOT (registered trademark) spotter using a discharge unit (inkjet method) described in Japanese Patent Application Laid-Open No. 2003-75305, and the spot was fixed by the following procedure.
  • GENSHOT registered trademark
  • DNA probe solution Forty-four oligo DNAs synthesized and dissolved in Tris-EDTA buffer were mixed with SSC buffer and bromophenol blue to prepare a DNA probe solution having a DNA probe concentration of 2 to 60 ⁇ M.
  • the inspection spot is performed again by adjusting the drive signal of the piezoelectric / electrostrictive element arranged in the ejection unit.
  • the drive signal was adjusted by changing the voltage value, the rising time to the predetermined voltage, the keeping time of the predetermined voltage value, and the voltage falling time. If a defect is still detected, the DNA probe solution is extracted from the discharge unit by vacuum suction, the DNA probe is injected again into the liquid injection section, and an inspection spot is performed. This operation was repeated until no defective spot was detected.
  • oligonucleotide probes were plotted on a sheet as shown in FIG. 1 by the following method. That is, for one type of DNA probe, the spot pitch is 0.05 mm in both the horizontal direction (X direction) and the vertical direction (Y direction), and nine spots are formed in both the horizontal direction and the vertical direction, and 0.5 mm in the horizontal direction.
  • One immobilization area having a square shape of 0.5 mm in the vertical direction was formed.
  • immobilization regions were formed and arranged from 47 types of DNA probe solutions in a 5 ⁇ 10 grid area with a square pitch of 0.6 mm in both the vertical and horizontal directions, and a plurality of immobilization regions were formed.
  • One section (5.9 mm ⁇ 2.9 mm) was formed.
  • 120 sections were formed on one sheet at a pitch of 13.5 mm in the vertical direction and a pitch of 6.8 mm in the horizontal direction.
  • FIG. 2 shows an outline of the process.
  • Hybridization process Each of the arrays prepared in Example 1 was put into each tube so that the color sample area was on top, and inserted into a heat block controlled at 60 ° C., and hybridization was carried out for 15 minutes.
  • the solution used in the hybridization step was once removed, 200 ⁇ l of hybridization solution was newly added to the array in the tube, and the hybridization solution was removed by heating in a heat block at 60 ° C. for 1 minute. Thereafter, the hybridization solution was changed in the same manner, and washing was repeated for 10 minutes and 1 minute, respectively.
  • Substrate reaction process 200 ⁇ l of peroxidase substrate solution (manufactured by Vec. Lab, TMB kit) was supplied to the washed tube, and an enzyme reaction was performed at room temperature to produce a blue reaction product.
  • the plurality of immobilization regions are square-shaped and aligned in 5 rows ⁇ 10 columns, and the aspect ratio is about 2, the detection signals of the plural immobilization regions are combined. Thus, it was easy to discriminate the patterns obtained, and the four types of Mycobacterium tuberculosis could be quickly determined.

Abstract

[Problem] To provide a more practical method for detecting a target polynucleotide. [Solution] An array provided with a plurality of immobilization regions for an oligonucleotide probe preassociated with a target polynucleotide on solid-phase support is prepared; the oligonucleotide probe on the array and an analyte are hybridized; a macroscopically visible detection signal is applied to a double-stranded hybridized product obtained by hybridization; and the target polynucleotide is detected on the basis of the detection signal. Hybridization is carried out in 1 mL or less of liquid per array.

Description

標的ポリヌクレオチドの検出方法及びアレイTarget polynucleotide detection method and array
 本明細書は、標的ポリヌクレオチドの検出方法、そのためのアレイ等に関する。
(関連出願の参照)
 本願は、2011年6月28日に出願された日本国特許出願である特願2011-143441に基づく優先権を主張するものであり、その内容は引用により本明細書に援用される。
The present specification relates to a method for detecting a target polynucleotide, an array therefor, and the like.
(Refer to related applications)
This application claims priority based on Japanese Patent Application No. 2011-143441, filed on June 28, 2011, the contents of which are incorporated herein by reference.
 従来より、生体試料の遺伝子中の特定のヌクレオチドや塩基配列を標的として、その生体を同定するなどの検査が行われている。例えば、結核菌の型別に必要な遺伝子領域をPCR法にて増幅し、この増幅産物をメンブレン上に固定されたオリゴヌクレオチドプローブをハイブリダイズさせることによって菌株の型判別をする検査が挙げられる。 Conventionally, tests such as identifying a living body by targeting a specific nucleotide or base sequence in a gene of a biological sample have been performed. For example, a gene region required for each type of Mycobacterium tuberculosis is amplified by a PCR method, and the amplification product is hybridized with an oligonucleotide probe fixed on a membrane, thereby testing the strain type.
 この種の方法としては、例えば、検出しようとする菌の型別に必要な特異的プローブを数十種類準備し、これらのプローブを平行線状のパターンで固定化したメンブレンを用いる方法がある。この方法では、試料から調製したPCR産物をブロッターを用いてこれらのプローブのラインパターンと垂直になるように供給してハイブリダイズさせる。この方法を実施するためのキットは市販もされている。 As this type of method, for example, there is a method using a membrane in which dozens of specific probes necessary for each type of bacteria to be detected are prepared and these probes are immobilized in a parallel line pattern. In this method, a PCR product prepared from a sample is supplied and hybridized using a blotter so as to be perpendicular to the line pattern of these probes. Kits for carrying out this method are also commercially available.
 この方法では、PCR用プライマーの一方の端がビオチン標識されているため、ハイブリダイゼーション後のメンブレンをペルオキシダーゼ標識ストレプトアビジンでインキュベートする。これにより、ハイブリダイズしたPCR産物をペルオキシダーゼで標識し、ECL試薬による化学発光シグナルをX線フィルムへ感光させる。こうして、生体試料に含まれている菌の型に応じて表出される特異的プローブの配列パターンに基づき型判別が可能となる。 In this method, since one end of the PCR primer is labeled with biotin, the membrane after hybridization is incubated with peroxidase-labeled streptavidin. Thereby, the hybridized PCR product is labeled with peroxidase, and the chemiluminescence signal from the ECL reagent is exposed to the X-ray film. In this way, the type can be determined based on the sequence pattern of the specific probe expressed according to the type of bacteria contained in the biological sample.
 標的ポリヌクレオチドの検出を容易にするため、試験紙などに、2種類以上の生理活性物質を固定しておき、生理活性物質同士が隣接することにより、目視で容易に生理的複合反応の検出を行うことも検討されている(特許文献1)。また、核酸プローブがスポットされた周囲に蛍光標識された試薬などをスポッティングすることで、標的物質と結合した核酸プローブの位置を特定するのを容易にすることも試みられている(特許文献2)。 In order to facilitate the detection of the target polynucleotide, two or more types of physiologically active substances are fixed on a test paper or the like, and the physiologically active substances are adjacent to each other so that a physiological complex reaction can be easily detected visually. It is also being studied (Patent Document 1). In addition, it has been attempted to easily identify the position of a nucleic acid probe bound to a target substance by spotting a fluorescently labeled reagent or the like around the spot where the nucleic acid probe is spotted (Patent Document 2). .
特開2007-64927号公報JP 2007-64927 A 特開2000-270896号公報JP 2000-270896 A
 しかしながら、上記した従来の方法では、いずれも、検体毎の検査や、小数検体での検査は困難であった。すなわち、上記した典型的な市販キットでは、ブロッターを用いてハイブリダイゼーションを行う手法であるため、大きな(14cm四方)メンブレン上に数十種のプローブが固相化されており、サンプルも1度に数十検体までハイブリダイゼーションできるが、検体数が少ない場合でも同量の試薬を使用し、同様の処理を行わなければならなかった。また、こうした事情によって、検体ごとに検査することは困難であった。 However, in each of the conventional methods described above, it is difficult to perform a test for each sample or a test with a small number of samples. That is, the above-described typical commercial kit is a method of performing hybridization using a blotter, and therefore, several tens of kinds of probes are immobilized on a large (14 cm square) membrane, and a sample is also prepared at a time. Although several tens of samples can be hybridized, even when the number of samples was small, the same amount of reagent was used and the same treatment had to be performed. In addition, due to such circumstances, it is difficult to test each specimen.
 さらに、上記市販キットでは、ハイブリダイゼーションや洗浄工程の間は温度を特定の一定温度に保たねばならないが、気相で加温するインキュベーターを使用するため温度の厳密な制御が難しく、非特異的結合による誤判定に繋がりやすい。更に、気相によるインキュベートはメンブレンが大きいことも影響して定温に達するまで時間が掛かっていた。加えて、検出工程については、プライマーが標識されているためPCR増幅断片1つについて得られるシグナルが1つであり、この検出感度の低さを補うため化学発光試薬とX線フィルムへの感光を採用しており、コストと作業時間の増加に繋がっている。 Furthermore, in the above-mentioned commercial kit, the temperature must be kept at a specific constant temperature during the hybridization and washing steps. However, since an incubator that heats in the gas phase is used, it is difficult to strictly control the temperature, and it is nonspecific. It is easy to lead to misjudgment by combination. Furthermore, incubation in the gas phase took time until it reached a constant temperature due to the large membrane. In addition, in the detection process, since the primer is labeled, one signal is obtained for each PCR amplified fragment. To compensate for this low detection sensitivity, the chemiluminescent reagent and X-ray film are exposed to light. Adopting this leads to an increase in cost and working time.
 特許文献1には、比較的小面積の試験片(60~300mm2)が開示されているが、検体毎の個別のかつ迅速な要請に応えるものではない。さらに、特許文献2には、Cy5をはじめとした蛍光物質を大量に必要とすること及び専用のスキャナを必要とすることから、コスト増となる。 Patent Document 1 discloses a test piece (60 to 300 mm 2 ) having a relatively small area, but does not meet individual and prompt requests for each specimen. Furthermore, since Patent Document 2 requires a large amount of a fluorescent material such as Cy5 and a dedicated scanner, the cost increases.
 そこで、本明細書は、より実用的な標的ポリヌクレオチドの検出方法やそのためのアレイを提供することを一つの目的とする。 Therefore, an object of the present specification is to provide a more practical method for detecting a target polynucleotide and an array therefor.
 本発明者らは、より実用的な標的ポリヌクレオチドの検出方法、すなわち、検体数の低減化、最も好ましくは検体毎の検査実施を可能にすることができるような、検出方法及びそのためのアレイについて検討した。より具体的には迅速性、簡易性及び低コスト性等を実現できる、検出方法及びそのためのアレイについて検討した。その結果、反応系サイズのコンパクト化と検出の肉眼による可視化とを、実現できることを見出した。本発明によれば、以下の手段が提供される。 The present inventors provide a more practical method for detecting a target polynucleotide, that is, a detection method and an array therefor, which can reduce the number of specimens, and most preferably enable a test to be performed for each specimen. investigated. More specifically, a detection method and an array therefor have been studied that can realize speediness, simplicity, and low cost. As a result, it was found that the reaction system can be made compact and the detection can be visualized with the naked eye. According to the present invention, the following means are provided.
(1)標的ポリヌクレオチドの検出方法であって、
 標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を固相担体上に備えるアレイ上の前記オリゴヌクレオチドプローブと、被験試料とにつき、ハイブリダイゼーションを実施する工程と、
 前記ハイブリダイゼーションで得られた二重鎖ハイブリダイズ産物に肉眼で視認可能な検出シグナルを付与する工程と、
 前記検出シグナルに基づいて標的ポリヌクレオチドを検出する工程と、
を備え、
 前記ハイブリダイゼーション工程は、前記アレイを用いて、前記アレイ毎に1ml以下の液中でハイブリダイゼーションを実施する工程とする、検出方法。
(2) 前記ハイブリダイゼーション工程は、前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記固相担体が、平面積が150mm2以下、アスペクト比が1.5以上のシート状体である前記アレイを用いて、ハイブリダイゼーションを実施する工程とする、(1)に記載の検出方法。
(3)前記ハイブリダイゼーション工程は、前記固相担体が、平面積が50mm2以下のシート状体である前記アレイを用いて、前記アレイ毎に0.3ml以下の液中でハイブリダイゼーションを実施する工程とする、(1)又は(2)に記載の検出方法。
(4)前記アスペクト比が20以下である、(1)~(3)のいずれかに記載の検出方法。
(5)前記アレイは、前記固相担体上に前記検出シグナルによる発色見本領域を別途備える、(1)~(4)のいずれかに記載の検出方法。
(6)前記発色見本領域は、顔料系インクにより形成されている、(5)に記載の検出方法。
(7)前記アレイは、検出シグナルの色調又は濃淡につき程度の異なる2種以上の前記発色見本領域を備える、(5)又は(6)に記載の検出方法。
(8)前記アレイは、検出シグナルの色調又は濃淡の上限及び下限に相当する2つの前記発色見本領域を少なくとも備えており、
 前記検出工程は、前記上限及び下限を指標として、前記標的ポリヌクレオチドを検出する工程とする、(7)に記載の検出方法。
(9)前記固相担体は、液体の浸透性又は透過性を有する、(1)~(8)のいずれかに記載の検出方法。
(10)前記固相担体は、ポリエーテルスルホン、ニトロセルロース、ナイロン、ポリフッ化ビニリデン及びろ紙から選択される、(9)に記載の検出方法。
(11)前記固相担体の厚みは、0.01mm以上0.3mm以下である、(1)~(10)のいずれかに記載の検出方法。
(12)前記アレイは、前記複数個の固定化領域の外縁の所定の一部にハンドリング部位を備える、(1)~(11)のいずれかに記載の検出方法。
(13)前記ハイブリダイゼーション工程及び前記シグナル付与工程を、前記アレイを所定の方向性で同一のチューブ状容器に投入した状態を維持して実施する、(1)~(12)のいずれかに記載の検出方法。
(14)さらに、前記検出工程を、前記アレイを所定の方向性で前記容器に投入した状態を維持して実施する、(13)に記載の検出方法。
(15)前記ハイブリダイゼーション工程に先立って、前記容器内で遺伝子増幅反応により被験試料を作製する工程を備える、(13)又は(14)に記載の検出方法。
(16)前記検出工程は、所定の複数の前記固定化領域から得られる検出シグナルの組み合わせに基づいて複数の前記標的ポリヌクレオチドを検出する工程である、(1)~(15)のいずれかに記載の検出方法。
(17)前記検出工程は、前記組み合わせを、前記アレイ上において得られた前記固定化領域の発色パターンと、前記組み合わせに対応する前記オリゴヌクレオチドプローブの発色パターン見本と対比して検出する工程である、(16)に記載の検出方法。
(18)前記固定化領域は、2個以上200個以下である、(1)~(17)のいずれかに記載の検出方法。
(19)前記オリゴヌクレオチドプローブは、正規直交配列である塩基配列を有するプローブである、(1)~(18)のいずれかに記載の検出方法。
(20)(1)~(19)のいずれかに記載の検出方法に用いるアレイであって、
 標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域と、肉眼で視認可能な検出シグナルによる発色を提示する発色見本領域と、を固相担体上に備え、
 前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記固相担体が、平面積が150mm2以下、アスペクト比が1.5以上20以下のシート状体である、アレイ。
(21)標的ポリヌクレオチドを検出するためのアレイのシートであって、
 標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域と、肉眼で視認可能な検出シグナルによる発色を提示する発色見本領域と、有するアレイ領域を複数個固相担体上に備えており、
 前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記アレイ領域が、平面積が150mm2以下、アスペクト比が1.5以上20以下であり、
 前記固相担体は、前記アレイ領域毎に分離可能である、シート。
(1) A method for detecting a target polynucleotide, comprising:
Performing hybridization on the test sample and the oligonucleotide probe on the array comprising a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide on a solid phase carrier; and
Providing a double-stranded hybridization product obtained by the hybridization with a detection signal that can be visually recognized by the naked eye;
Detecting a target polynucleotide based on the detection signal;
With
The detection method, wherein the hybridization step is a step of performing hybridization in a solution of 1 ml or less for each array using the array.
(2) In the hybridization step, the size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, and the solid phase carrier has a plane area of 150 mm 2 or less and an aspect ratio of 1.5 or more. The detection method according to (1), wherein hybridization is performed using the array that is a sheet-like body.
(3) In the hybridization step, hybridization is performed in a solution of 0.3 ml or less for each array, using the array in which the solid phase carrier is a sheet-like body having a plane area of 50 mm 2 or less. The detection method according to (1) or (2), which is a step.
(4) The detection method according to any one of (1) to (3), wherein the aspect ratio is 20 or less.
(5) The detection method according to any one of (1) to (4), wherein the array is separately provided with a color development sample region based on the detection signal on the solid phase carrier.
(6) The detection method according to (5), wherein the color sample area is formed of pigment-based ink.
(7) The detection method according to (5) or (6), wherein the array includes two or more kinds of the color development sample regions having different degrees according to the color tone or shading of a detection signal.
(8) The array includes at least two color sample regions corresponding to the upper limit and the lower limit of the color tone or shading of the detection signal,
The detection method according to (7), wherein the detection step is a step of detecting the target polynucleotide using the upper limit and the lower limit as indices.
(9) The detection method according to any one of (1) to (8), wherein the solid phase carrier has liquid permeability or permeability.
(10) The detection method according to (9), wherein the solid phase carrier is selected from polyethersulfone, nitrocellulose, nylon, polyvinylidene fluoride, and filter paper.
(11) The detection method according to any one of (1) to (10), wherein the thickness of the solid phase carrier is 0.01 mm or more and 0.3 mm or less.
(12) The detection method according to any one of (1) to (11), wherein the array includes a handling portion at a predetermined part of an outer edge of the plurality of immobilization regions.
(13) The hybridization step and the signal imparting step are performed while maintaining the state in which the array is put in the same tube-shaped container in a predetermined direction. (13) Detection method.
(14) The detection method according to (13), wherein the detection step is performed while maintaining the state where the array is put into the container with a predetermined direction.
(15) The detection method according to (13) or (14), comprising a step of preparing a test sample by a gene amplification reaction in the container prior to the hybridization step.
(16) The detection step is a step of detecting a plurality of the target polynucleotides based on a combination of detection signals obtained from a predetermined plurality of the immobilized regions. The detection method described.
(17) The detection step is a step of detecting the combination in comparison with the coloring pattern of the immobilized region obtained on the array and the coloring pattern sample of the oligonucleotide probe corresponding to the combination. The detection method according to (16).
(18) The detection method according to any one of (1) to (17), wherein the number of the immobilized regions is 2 or more and 200 or less.
(19) The detection method according to any one of (1) to (18), wherein the oligonucleotide probe is a probe having a base sequence that is an orthonormal sequence.
(20) An array used for the detection method according to any one of (1) to (19),
A plurality of immobilization regions of oligonucleotide probes pre-associated with the target polynucleotide and a color sample region that presents color development by a detection signal that can be visually recognized by the naked eye are provided on a solid phase carrier.
The size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, and the solid phase carrier is a sheet-like body having a plane area of 150 mm 2 or less and an aspect ratio of 1.5 or more and 20 or less. .
(21) An array sheet for detecting a target polynucleotide comprising:
Provided with a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide, a color sample region that presents color development by a detection signal visible to the naked eye, and a plurality of array regions on a solid phase carrier And
The size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, the array region has a plane area of 150 mm 2 or less, and an aspect ratio of 1.5 or more and 20 or less,
The solid phase carrier is a sheet that is separable for each array region.
本発明のアレイ及びアレイシートの一例を示す図である。It is a figure which shows an example of the array and array sheet | seat of this invention. 本発明の検出方法の一例を示す図である。It is a figure which shows an example of the detection method of this invention.
 本明細書は、標的ポリヌクレオチドの検出方法及びそのためのアレイ等に関する。本明細書に開示される検出方法は、小スケールで、迅速かつ簡易に標的ポリヌクレオチドを検出することができる。反応系の小スケール化は、試薬量の低減による低コスト化のほか、アレイの小スケール化によって、精度がよく迅速な温度制御が可能となる。さらに、可視光による検出は、装置コストを低減できるほか、リアルタイムに発色を観察できる点が検査の迅速性に寄与している。 This specification relates to a method for detecting a target polynucleotide, an array for the same, and the like. The detection method disclosed in the present specification can detect a target polynucleotide quickly and easily on a small scale. Reducing the scale of the reaction system can reduce the cost by reducing the amount of the reagent, and by controlling the scale of the array, the temperature can be controlled with high accuracy and speed. Furthermore, the detection by visible light can reduce the cost of the apparatus, and the observation of color development in real time contributes to the speed of inspection.
 本明細書に開示されるアレイ及びシートによれば、こうした小スケール反応に適したものとなっており、特に、0.5ml以下のチューブ状容器への適用性に優れたものとなっている。 The array and sheet disclosed in the present specification are suitable for such a small-scale reaction, and particularly excellent in applicability to a tubular container of 0.5 ml or less.
 本明細書において、標的ポリヌクレオチドは、ヌクレオチドの重合体を意味しており、その数は特に限定しない。したがって、標的ポリヌクレオチドには、数十程度のヌクレオチドが連結したオリゴヌクレオチドが包含される。標的ポリヌクレオチドは、例えば、体質、遺伝病、癌などの特定疾患についての発症、疾患診断、治療予後、薬剤や治療の選択などのヒト、非ヒト動物などの生物における遺伝子上の指標となる塩基あるいは塩基配列を含んでいる。典型的には、SNPなどの多型や先天的又は後天的変異が挙げられる。また、病原菌やウイルスなどの微生物由来の塩基配列も標的ポリヌクレオチドが有する塩基配列として挙げられる。 In this specification, the target polynucleotide means a polymer of nucleotides, and the number thereof is not particularly limited. Therefore, the target polynucleotide includes an oligonucleotide in which several tens of nucleotides are linked. The target polynucleotide is a base that serves as a genetic index in organisms such as humans and non-human animals, such as constitution, genetic disease, onset of specific diseases such as cancer, disease diagnosis, treatment prognosis, drug and treatment selection, etc. Or the base sequence is included. Typically, polymorphisms such as SNP and congenital or acquired mutations can be mentioned. In addition, base sequences derived from microorganisms such as pathogenic bacteria and viruses are also exemplified as base sequences possessed by the target polynucleotide.
 以下では、本発明の代表的かつ非限定的な具体例について、図面を参照して詳細に説明する。この詳細な説明は、本発明の好ましい例を実施するための詳細を当業者に示すことを単純に意図しており、本発明の範囲を限定することを意図したものではない。また、以下に開示される追加的な特徴ならびに発明は、さらに改善された標的ポリヌクレオチドの検出方法及びアレイを提供するために、他の特徴や発明とは別に、又は共に用いることができる。 Hereinafter, representative and non-limiting specific examples of the present invention will be described in detail with reference to the drawings. This detailed description is intended merely to present those skilled in the art with the details for practicing the preferred embodiments of the present invention and is not intended to limit the scope of the invention. In addition, the additional features and inventions disclosed below can be used separately or together with other features and inventions to provide further improved methods and arrays for detecting target polynucleotides.
 また、以下の詳細な説明で開示される特徴や工程の組み合わせは、最も広い意味において本発明を実施する際に必須のものではなく、特に本発明の代表的な具体例を説明するためにのみ記載されるものである。さらに、上記及び下記の代表的な具体例の様々な特徴、ならびに、独立及び従属クレームに記載されるものの様々な特徴は、本発明の追加的かつ有用な実施形態を提供するにあたって、ここに記載される具体例のとおりに、あるいは列挙された順番のとおりに組合せなければならないものではない。 Further, the combinations of features and steps disclosed in the following detailed description are not indispensable when practicing the present invention in the broadest sense, and are particularly only for explaining representative specific examples of the present invention. It is described. Moreover, various features of the representative embodiments described above and below, as well as those described in the independent and dependent claims, are described herein in providing additional and useful embodiments of the invention. They do not have to be combined in the specific examples given or in the order listed.
 本明細書及び/又はクレームに記載された全ての特徴は、実施例及び/又はクレームに記載された特徴の構成とは別に、出願当初の開示ならびにクレームされた特定事項に対する限定として、個別に、かつ互いに独立して開示されることを意図するものである。さらに、全ての数値範囲及びグループ又は集団に関する記載は、出願当初の開示ならびにクレームされた特定事項に対する限定として、それらの中間の構成を開示する意図を持ってなされている。 All features described in this specification and / or claims, apart from the configuration of the features described in the examples and / or claims, are individually disclosed as limitations on the original disclosure and claimed specific matters. And are intended to be disclosed independently of each other. Further, all numerical ranges and group or group descriptions are intended to disclose intermediate configurations thereof as a limitation to the original disclosure and claimed subject matter.
 以下、本明細書に開示される実施形態について説明する。 Hereinafter, embodiments disclosed in the present specification will be described.
(標的ポリヌクレオチドの検出方法)
 本明細書に開示される検出方法は、ハイブリダイゼーション工程と、シグナルを付与する工程と、標的ポリヌクレオチドの検出工程と、を備えている。
(Target polynucleotide detection method)
The detection method disclosed in the present specification includes a hybridization step, a signal imparting step, and a target polynucleotide detection step.
(ハイブリダイゼーション工程)
 ハイブリダイゼーション工程は、標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を固相担体上に備えるアレイを準備し、このアレイ上の前記オリゴヌクレオチドプローブと、被験試料とにつき、前記アレイ毎に1ml以下の液中でハイブリダイゼーションを実施するハイブリダイゼーションを実施する工程とすることができる。以下、まず本方法において用いる本発明のアレイについて説明する。
(Hybridization process)
The hybridization step prepares an array comprising a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide on a solid phase carrier, and the oligonucleotide probe on the array and the test sample are It can be set as the process of performing the hybridization which implements hybridization in a 1 ml or less solution for every said array. Hereinafter, the array of the present invention used in this method will be described first.
(アレイ)
 本明細書に開示されるアレイは、標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を固相担体上に備えている。本アレイは、上記のとおり、アレイ一つにつき1ml以下の液中ハイブリダイゼーション可能な程度の形態を有している。すなわち、当該形態(サイズ及び形状)の固相担体を備えている。
(array)
The array disclosed herein comprises a plurality of immobilized regions of oligonucleotide probes pre-associated with a target polynucleotide on a solid support. As described above, this array has a form that allows hybridization in a liquid of 1 ml or less per solution. That is, the solid support of the said form (size and shape) is provided.
 アレイに1ml以下の液中ハイブリダイゼーションを可能とする形態は、ハイブリダイゼーション容器の大きさによっても異なるが、本明細書では、当該容器として、例えば、先細りのあるいは寸胴状のチューブ状容器が意図されることが好ましい。すなわち、こうした容器を用いて本検出方法を実施することが好ましい。先細り状の容器の例としては、典型的には、エッペンドルフチューブ(商品名)が挙げられ、寸胴状の容器の例としては、典型的には一般的な試験管等が挙げられる。チューブ状容器は、例えば、1ml以下、0.5ml以下、0.3ml以下のハイブリダイゼーション液を充填できる容積を有することが好ましい。こうしたチューブ状容器としては、それぞれ、内径7~9mm、典型的には8mm、深さ37~39mm、典型的には38mm、内径5~7mm、典型的には6mm、深さ29~31mm、典型的には30mm及び内径4~6mm、典型的には5mm、深さ19~21mm、典型的には20mmのサイズを有するものが挙げられる。 The form that allows hybridization in a solution of 1 ml or less in the array varies depending on the size of the hybridization container. In this specification, for example, a tapered or cylindrical tube container is intended as the container. It is preferable. That is, it is preferable to implement this detection method using such a container. An example of the tapered container is typically an Eppendorf tube (trade name), and an example of a cylindrical container is typically a general test tube. The tube-like container preferably has a volume capable of being filled with, for example, 1 ml or less, 0.5 ml or less, and 0.3 ml or less hybridization solution. Such tubular containers each have an inner diameter of 7-9 mm, typically 8 mm, a depth of 37-39 mm, typically 38 mm, an inner diameter of 5-7 mm, typically 6 mm, a depth of 29-31 mm, typically Specifically, those having a size of 30 mm and an inner diameter of 4 to 6 mm, typically 5 mm, a depth of 19 to 21 mm, and typically 20 mm can be mentioned.
 容器は、また、透明性であることが好ましい。内部のアレイの状態、ひいては検出シグナルを肉眼で視認するのに都合がよいからである。また、容器は、その開口部(通常は上部)を開閉するために脱着可能な蓋を備えていてもよい。こうした蓋を備えることで、少ない液量の蒸発等を防ぐとともに、温度制御を迅速かつ容易化できる。 The container is also preferably transparent. This is because it is convenient to visually check the state of the internal array, and thus the detection signal. Moreover, the container may be provided with a detachable lid to open and close its opening (usually the upper part). By providing such a lid, it is possible to prevent evaporation of a small amount of liquid and the like and to quickly and easily control the temperature.
 より具体的には、アレイの形態は、平面積が150mm2以下であることが好ましい。この平面積以下であると、十分に1ml以下の液中においても固定化領域においてハイブリダイゼーションが可能である。より好ましくは、100mm2以下であり、さらに好ましくは50mm2以下である。50mm2以下であると、0.3ml以下の液中でのハイブリダイゼーションにも有効である。 More specifically, the form of the array preferably has a plane area of 150 mm 2 or less. When the area is less than this plane area, hybridization is possible in the immobilization region even in a solution of 1 ml or less. More preferably, it is 100 mm 2 or less, and further preferably 50 mm 2 or less. When it is 50 mm 2 or less, it is also effective for hybridization in a solution of 0.3 ml or less.
 また、好ましくは、アスペクト比が1.5以上の方形状である。こうした方形状であると、チューブ状容器に収まりやすく、ハンドリングも容易である。また、チューブ状容器内で反転したりせずに、容器内において投入時の形態が保持され、予め定めた一定の方向性が確保される。さらに、方形状であると、アレイの方向性を目視で簡易に判別することができ、ハイブリダイゼーション工程ほか、シグナル付与工程及び検出工程に都合がよい。より好ましくはアスペクト比が20以下である。アスペクト比が20を超えると固定化領域の検出パターンを把握しにくくなるからであり、20以下であると複数個の固定化領域におけるシグナルを目視でパターンとして把握しやすいため、検出精度を維持ないし向上させることができる。アスペクト比は好ましくは15以下であり、より好ましくは10以下であり、さらに好ましくは5以下であり、一層好ましくは3以下である。 Also preferably, the rectangular shape has an aspect ratio of 1.5 or more. Such a square shape is easy to fit in a tubular container and is easy to handle. Moreover, the form at the time of injection | throwing-in is hold | maintained in a container, without reversing in a tube-shaped container, and the predetermined fixed directionality is ensured. Furthermore, when the shape is rectangular, the directionality of the array can be easily determined visually, which is convenient for the hybridization step, the signal application step, and the detection step. More preferably, the aspect ratio is 20 or less. This is because when the aspect ratio exceeds 20, it is difficult to grasp the detection pattern of the fixed region. When the aspect ratio is 20 or less, it is easy to visually grasp the signals in the plurality of fixed regions as a pattern. Can be improved. The aspect ratio is preferably 15 or less, more preferably 10 or less, still more preferably 5 or less, and even more preferably 3 or less.
 アレイは、シート状であることが好ましい。シート状であると、ハンドリング性が良く、検査データとしての保存にも有利である。さらに、シート状であると、一定の可撓性も付与しやすく、小スケールの容器への充填性、収納性及び反応性に有利に寄与することができる。アレイの厚みは、固相担体の厚みとして、0.01mm以上0.3mm以下であることが好ましい。 The array is preferably in the form of a sheet. When it is in the form of a sheet, it is easy to handle and is advantageous for storage as inspection data. Furthermore, when it is in the form of a sheet, it is easy to impart a certain degree of flexibility, which can advantageously contribute to the filling property, storage property, and reactivity in a small-scale container. The thickness of the array is preferably 0.01 mm or more and 0.3 mm or less as the thickness of the solid phase carrier.
(オリゴヌクレオチドプローブの固定化領域)
 アレイは、固相担体上に標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を備えている。オリゴヌクレオチドプローブは、検出する対象や検出手法、あるいは標的ポリヌクレオチドの検出システムに応じて適宜選択される。例えば、感染症等の感染原因菌の菌種(型)判定には、複数のオリゴヌクレオチドプローブに対するハイブリダイゼーションによって検出する。変異の検出にあたっては、一つの変異に対して1又は複数のオリゴヌクレオチドプローブの固定化領域を対応させてもよい。
(Immobilization region of oligonucleotide probe)
The array comprises a plurality of immobilization regions of oligonucleotide probes pre-associated with a target polynucleotide on a solid support. The oligonucleotide probe is appropriately selected according to the object to be detected, the detection technique, or the target polynucleotide detection system. For example, in order to determine the species (type) of an infectious agent such as an infectious disease, detection is performed by hybridization with a plurality of oligonucleotide probes. In detecting a mutation, one or a plurality of oligonucleotide probe immobilization regions may correspond to one mutation.
 オリゴヌクレオチドプローブとしては、標的ポリヌクレオチドの塩基配列にかかわらず、常に所定の塩基配列を有するプローブである、ユニバーサルプローブを用いてもよい。ユニバーサルプローブは、たとえば乱数から得られた所定塩基長のDNA配列に対して連続一致長、Nearest-Neighbor法による融解温度予測、ハミング距離、二次構造予測の計算を行うことにより設計される塩基配列である正規直交配列を有することができる。正規直交配列は、核酸の塩基配列であって、その融解温度が均一であるもの、即ち融解温度が一定範囲内に揃うように設計された配列であって、核酸自身が分子内(intramolecular)で構造化して、相補的な配列とのハイブリッド形成を阻害することのない配列であり、尚且つこれに相補的な塩基配列以外とは安定したハイブリッドを形成しない塩基配列を意味しうる。1つの正規直交配列群に含まれる配列は、所望の組み合わせ以外の配列間および自己配列内において反応が生じ難いか、または反応が生じない。また、正規直交配列は、PCR等において増幅させると、たとえば上述のクロスハイブリダイズのような問題に影響されずに、当該正規直交配列を有する核酸の初期量に応じた量の核酸が定量的に増幅される性質を有しうる。上記のような正規直交配列は、H.Yoshida and A.Suyama,“Solution to 3-SAT by breadth first search”,DIMACS Vl.54, 9-20(2000)に詳細が記載されている。こうした文献に基づいて正規直交配列を設計することができる。 As the oligonucleotide probe, a universal probe that is always a probe having a predetermined base sequence may be used regardless of the base sequence of the target polynucleotide. A universal probe is a base sequence designed by, for example, calculating a continuous match length, melting temperature prediction by the Nearest-Neighbor method, Hamming distance, and secondary structure prediction for a DNA sequence of a predetermined base length obtained from a random number. Can have an orthonormal array. An orthonormal sequence is a base sequence of nucleic acid having a uniform melting temperature, that is, a sequence designed so that the melting temperature is within a certain range, and the nucleic acid itself is intramolecular. A base sequence that does not form a structure and does not inhibit hybridization with a complementary sequence, and that does not form a stable hybrid other than a complementary base sequence can be meant. A sequence included in one orthonormal sequence group hardly reacts between sequences other than the desired combination and within a self-sequence, or does not generate a reaction. Further, when the orthonormal sequence is amplified by PCR or the like, the amount of nucleic acid corresponding to the initial amount of the nucleic acid having the orthonormal sequence is quantitatively determined without being affected by the problem such as the above-described cross-hybridization. Can have the property of being amplified. The orthonormal sequences as described above are described in detail in H. Yoshida and A.Suyama, “Solution to 3-SAT by breadth first search”, DIMACS Vl.54, 9-20 (2000). An orthonormal array can be designed based on these documents.
 こうしたユニバーサルプローブを用いた場合、予め標的ポリヌクレオチドに対して特定のユニバーサルプローブを関連付けておく。そして、標的ポリヌクレオチドに対して、プライマーとのハイブリダイゼーション反応とリガーゼ反応とを実施して、関連付けられたユニバーサルプローブの塩基配列と同一又は相補的な塩基配列を有する標的ポリヌクレオチドに特異的なリガーゼ産物を取得し、このリガーゼ産物と、アレイ上のユニバーサルプローブとのハイブリダイゼーションを実施することとなる。リガーゼ産物は、予め関連付けられたプローブとハイブリダイズし二重鎖ハイブリダイズ産物を生成する。なお、SNPなど変異の検出には、一つの標的ポリヌクレオチドに対して、複数のユニバーサルプローブが割り付けられることもある。この種の方法は、特開2008-306941号公報、Analytical Biochemistry, 364, 1, 2007, 78-85の他、特開2009-232778号公報、特開2009-24号公報等を参照して実施することができる。 When such a universal probe is used, a specific universal probe is associated with the target polynucleotide in advance. Then, the target polynucleotide is subjected to a hybridization reaction with a primer and a ligase reaction, and a ligase specific to the target polynucleotide having a base sequence identical or complementary to the base sequence of the associated universal probe. A product is obtained, and hybridization between the ligase product and the universal probe on the array is performed. The ligase product hybridizes with a pre-associated probe to produce a double stranded hybridized product. For detection of mutation such as SNP, a plurality of universal probes may be assigned to one target polynucleotide. This type of method is carried out with reference to Japanese Patent Application Laid-Open No. 2008-306941, Analytical Biochemistry, 364, 1, 2007, 78-85, as well as JP2009-232778, JP2009-24, etc. can do.
 一つの固定化領域は、好ましくは一種類のオリゴヌクレオチドプローブが固定化されている。なお、オリゴヌクレオチドプローブの固相担体への固定化手法については、当業者であれば、公知の各種手法に必要に応じて適宜採用することができる。 In one immobilization region, preferably one kind of oligonucleotide probe is immobilized. As for the method for immobilizing the oligonucleotide probe to the solid phase carrier, those skilled in the art can appropriately adopt various known methods as necessary.
 個々の固定化領域の大きさは、0.2mm2以上150mm2以下である。0.2mm2未満であると目視による視認性が低下しすぎ、150mm2を超えてはアレイのサイズ上問題がある。 The size of each immobilization region is 0.2 mm 2 or more and 150 mm 2 or less. When the thickness is less than 0.2 mm 2 , the visual visibility is excessively lowered, and when it exceeds 150 mm 2 , there is a problem in the size of the array.
 固定化領域の形状は特に限定しないで、円形状、方形状等、アレイにおいて適用される公知の各種の形態とすることができる。固定化領域の充填密度や視認性を考慮すると方形状であることが好ましく、より好ましくは正方形状である。 The shape of the immobilization region is not particularly limited, and may be various known forms applied in the array, such as a circular shape and a rectangular shape. In view of the packing density and visibility of the immobilization region, a rectangular shape is preferable, and a square shape is more preferable.
 固定化領域の個数は、固定化領域の個数は、検出意図や検出方法の用途に応じて適宜設定される。アレイのサイズ等を考慮すると、特に限定しないが、2個以上200個以下であることが好ましい。200個を超えると、アレイのサイズ上の観点及び目視による検出判定が困難になる可能性があるからである。1又は複数の固定化領域における目視によるシグナル検出を考慮すると、好ましくは150個以下であり、より好ましくは100個以下である。また、固定化領域の個数は、好ましくは20個以上であり、より好ましくは40個以上である。20個以上であると、例えば、各種診断等において汎用性が高い。 The number of immobilization areas is appropriately set according to the purpose of detection and the use of the detection method. Considering the size of the array and the like, it is not particularly limited, but it is preferably 2 or more and 200 or less. This is because if the number exceeds 200, it may be difficult to determine the size of the array and to visually detect and judge. When visual signal detection in one or a plurality of immobilization regions is taken into consideration, it is preferably 150 or less, more preferably 100 or less. Further, the number of immobilization regions is preferably 20 or more, more preferably 40 or more. When it is 20 or more, for example, it is highly versatile in various diagnoses.
 複数個の固定化領域は、固相担体上に一つの区画を形成していることが好ましい。区画は、アレイの形状に応じた、たて列及びよこ列の組み合わせによる整列形態を備えていることが好ましい。典型的には、こうした区画は、方形状となっている。 It is preferable that the plurality of immobilization regions form one compartment on the solid support. It is preferable that the section has an alignment form by a combination of a vertical row and a horizontal row according to the shape of the array. Typically, these compartments are square.
(発色見本領域)
 アレイは、固相担体上に、複数の固定化領域の他に検出シグナルによる発色見本領域を別途備えることができる。こうした発色見本領域を備えることで、アレイが小スケール化されていても、また、目視によるシグナル判別によっても、検出精度及び正確性を確保することができる。発色見本領域は、後述するシグナル付与工程で付与するシグナルの発色見本であり、シグナルに応じた色調、明度や彩度をもって、予め付与されている。すなわち、検出方法を通じて維持できるように付与されている。発色見本領域は、インクによって、付与されており、好ましくは、固相担体への定着性や反応性を考慮して顔料インクが用いられる。こうしたインク類は、典型的には、オリゴヌクレオチドプローブを固相担体に付与して固定化領域を形成するときと同様の手法(例えば、ピエゾ素子によるインクジェット手法)で、固相担体に付与されている。そして、発色見本領域は、対比観察上の要請から、固定化領域と同様のサイズと形状で、固相担体上に付与されていることが好ましい。さらに、発色見本領域は、固定化領域におけるシグナルと対比観察がしやすいように、固定化領域に隣接して形成されていることが好ましい。
(Color sample area)
The array can be separately provided with a color sample region by a detection signal in addition to a plurality of immobilization regions on a solid phase carrier. By providing such a color sample area, the detection accuracy and accuracy can be ensured even if the array is reduced in scale or by visual signal discrimination. The color development sample region is a color development sample of a signal applied in a signal application step described later, and is provided in advance with a color tone, lightness, and saturation corresponding to the signal. That is, it is given so that it can be maintained through the detection method. The color sample area is provided by ink, and pigment ink is preferably used in consideration of fixability to a solid phase carrier and reactivity. Such inks are typically applied to a solid phase carrier in the same manner as when an oligonucleotide probe is applied to a solid phase carrier to form an immobilized region (for example, an inkjet method using a piezo element). Yes. The color development sample region is preferably provided on the solid phase carrier in the same size and shape as the immobilization region because of the requirement for comparative observation. Furthermore, it is preferable that the color development sample region is formed adjacent to the immobilization region so that it can be easily compared with the signal in the immobilization region.
 発色見本領域は、検出シグナルの色調又は濃淡につき程度の異なる2種以上の領域から構成されていることが好ましい。こうした構成とすることで、目視によるシグナル検出をより容易にかつ確実に行うことができる。好ましくは、検出シグナルの色調又は濃淡の上限及び下限に相当する少なくとも2つの発色見本領域を備える。こうした発色見本領域を備えることで、上記上限及び下限を指標としてシグナルの検出を判断できるようになり、試験者の熟練程度や反応誤差に関わらず一層容易かつ確実な検出が可能となる。 The color development sample region is preferably composed of two or more types of regions having different degrees of color or shade of the detection signal. With such a configuration, visual signal detection can be performed more easily and reliably. Preferably, at least two color sample regions corresponding to the upper limit and the lower limit of the color tone or shading of the detection signal are provided. By providing such a color sample area, signal detection can be determined using the above upper and lower limits as indices, and easier and more reliable detection is possible regardless of the skill level of the tester and reaction errors.
(ハンドリング部位)
 アレイは、複数個の固定化領域からなる区画の外部にハンドリング部位を備えることができる。ハンドリング部位を有することで、小さいアレイであってもハンドリングを確実にするとともに、一定の方向性でアレイを取り扱うことが可能となり、実験精度ないし検出精度を高め、シグナル検出も容易化することができる。ハンドリング部位としては、典型的には、固相担体上の固定化領域や発色見本領域が形成されていないマージン領域を適用することができる。また、ハンドリング部位をアレイの一部、例えば、方形状シートの一端部(特に一方の短縁部)に設けることで、アレイの取り扱いに便利であるほか、アレイを容易に一定の方向性を維持して各種操作を実施できる。ハンドリング部位には、アレイを個別に識別するための検体識別情報を付与することが可能であり、予めこうした検体識別情報を、インク等に付与されていてもよい。検体識別情報は、数字、記号、文字又は図形、これらの組み合わせであってよい。
(Handling part)
The array can be provided with a handling site outside the compartment consisting of a plurality of immobilization regions. By having a handling site, handling can be ensured even in a small array, the array can be handled in a certain direction, experimental accuracy or detection accuracy can be improved, and signal detection can be facilitated. . As the handling site, typically, a margin region in which an immobilization region or a color sample region on a solid phase carrier is not formed can be applied. In addition, it is convenient to handle the array by providing a handling part on a part of the array, for example, one end (especially one short edge) of the square sheet, and the array can be easily maintained in a certain direction. Various operations can be performed. The handling site can be provided with specimen identification information for individually identifying the array, and such specimen identification information may be previously given to ink or the like. The specimen identification information may be numbers, symbols, characters or figures, or a combination thereof.
 そのほか、アレイは、操作及び識別に有用な情報を備えることができる。例えば、操作や検出時におけるアレイの方向性を定める方向識別情報を付与することができる。なお、上記したマージン領域(ハンドリング部位)や発色見本領域、検体識別情報を、方向識別情報として用いることもできる。 Besides, the array can be equipped with information useful for operation and identification. For example, direction identification information that determines the directionality of the array at the time of operation or detection can be given. The margin area (handling part), color sample area, and specimen identification information described above can also be used as direction identification information.
(固相担体)
 アレイを構成する固相担体は、特に限定しないが、ダウンサイジング性、小スケールでの取り扱い性、反応性、検出シグナルの視認性等を考慮すると、液体の浸透性又は透過性を有することが好ましい。こうした材料としては、例えば、ポリエーテルスルホン、ニトロセルロース、ナイロン、ポリフッ化ビニリデンなどのポリマーを主体としたいわゆる多孔性のメンブランフィルターのほか、セルロースなどのろ紙を好ましく用いることができる。
(Solid phase carrier)
The solid phase carrier constituting the array is not particularly limited, but it is preferable to have liquid permeability or permeability in consideration of downsizing, handling on a small scale, reactivity, visibility of detection signal, and the like. . As such materials, for example, so-called porous membrane filters mainly composed of polymers such as polyethersulfone, nitrocellulose, nylon, and polyvinylidene fluoride, filter paper such as cellulose can be preferably used.
 ハイブリダイゼーション工程は、こうしたアレイを用いて、一つのアレイにつき1ml以下、好ましくは、0.5ml以下、より好ましくは0.3ml以下の液中でハイブリダイゼーションを実施する。ハイブリダイゼーション工程において、被験試料中に、プローブと塩基対を形成する標的ポリヌクレオチドを有するオリゴヌクレオチドを含んでいるとき、二重鎖ハイブリダイズ産物が形成される。 In the hybridization step, using such an array, hybridization is performed in a solution of 1 ml or less, preferably 0.5 ml or less, more preferably 0.3 ml or less per array. In the hybridization step, when the test sample contains an oligonucleotide having a target polynucleotide that forms a base pair with the probe, a double-stranded hybridization product is formed.
 ハイブリダイゼーション工程は、アレイを所定の方向でチューブ状容器に投入し、その状態を維持して実施することが好ましい。具体的には、チューブ状容器の内部形態に合わせて、アレイの長辺が容器の深さ方向に沿う状態を維持して実施することが好ましい。上記したアスペクト比の方形状シートのアレイを用いることで、市販で入手できる1~0.3ml程度の各種形態のチューブ状容器内に安定して保持される。 The hybridization step is preferably performed while the array is placed in a tubular container in a predetermined direction and maintained in that state. Specifically, it is preferable to carry out while maintaining a state in which the long side of the array is along the depth direction of the container in accordance with the internal form of the tubular container. By using the array of rectangular sheets having the aspect ratio described above, it can be stably held in various forms of tubular containers of about 1 to 0.3 ml that are commercially available.
 ハイブリダイゼーション工程では、チューブ状容器を用いる場合、既存のPCRのための温度制御装置に適用することができる。こうした温度制御を実施することで、精度よくかつ迅速に温度制御が可能となる。ハイブリダイゼーション工程の条件は特に限定しない。通常のハイブリダイズ媒体を用いることができる。また、適度な温度に設定することができる。 In the hybridization step, when a tube-like container is used, it can be applied to an existing temperature control device for PCR. By performing such temperature control, temperature control can be performed accurately and quickly. The conditions for the hybridization step are not particularly limited. A normal hybridization medium can be used. Moreover, it can set to moderate temperature.
 なお、後段の検出工程に先立って、過剰の被験試料を洗浄除去する洗浄工程を実施することが好ましい。洗浄工程は、ハイブリダイゼーション工程を実施した容器からハイブリダイゼーション液を除去してアレイのみを残留させた状態で、所定の温度条件で洗浄に適した液を供給して適当な時間接触させることを適数回繰り返すことによって実施できる。こうした洗浄工程を同一容器で実施することで、操作を簡略化し容器数を減らしてしかも、温度制御を迅速かつ精度よく行うことができる。 In addition, it is preferable to carry out a washing step for washing and removing excess test sample prior to the subsequent detection step. In the washing step, it is appropriate to remove the hybridization solution from the container in which the hybridization step has been performed and leave only the array, and then supply a solution suitable for washing under a predetermined temperature condition and contact for a suitable time. This can be done by repeating several times. By carrying out such a cleaning process in the same container, the operation can be simplified, the number of containers can be reduced, and temperature control can be performed quickly and accurately.
 ハイブリダイゼーション工程に供する被験試料は、特に限定しないで、ハイブリダイゼーションの対象となる可能性のある標的ポリヌクレオチドを含んでいればよい。被験試料としては、プローブハイブリダイゼーションが適用される公知の遺伝子情報、DNAを用いた検出、検査、診断方法における被験試料を本方法に用いることができる。 The test sample to be subjected to the hybridization step is not particularly limited as long as it contains a target polynucleotide that may be a target of hybridization. As a test sample, known gene information to which probe hybridization is applied, a test sample in a detection, test, or diagnostic method using DNA can be used in this method.
 被験試料には、各種の生体由来の試料(血液、尿、痰、組織、細胞(各種の動物由来の培養動物細胞、培養植物細胞、培養微生物細胞を含む))あるいは、こうした生体試料からDNAを抽出したDNA抽出試料、こうした生体試料の有するDNAやRNAから各種の遺伝子増幅手法による増幅試料等が含まれる。また、後述するシグナル付与工程を考慮すると、被験試料中のオリゴヌクレオチドが予め標識されていることが好ましい。当業者であれば、こうした被験試料を周知の技術に基づいて容易に調製することができるが、例えば、以下の被験試料調製工程を実施してもよい。 Test samples include various biological samples (blood, urine, sputum, tissue, cells (including cultured animal cells, cultured plant cells, cultured microbial cells derived from various animals)) or DNA from such biological samples. Extracted DNA extracted samples, amplified samples by various gene amplification techniques from DNA and RNA of such biological samples are included. In consideration of the signal providing step described later, it is preferable that the oligonucleotide in the test sample is labeled in advance. A person skilled in the art can easily prepare such a test sample based on a well-known technique. For example, the following test sample preparation process may be performed.
(被験試料調製工程)
 本発明方法は、ハイブリダイゼーション工程に先立って、ハイブリダイゼーション工程に用いる容器と同一容器を用いて、遺伝子増幅反応によって被験試料を調製する工程を備えていてもよい。同一容器を用いることで、増幅に用いた容器に対してアレイを投入することでハイブリダイゼーション工程を実施できる。また、こうすることで、用いる容器数を減少させ、操作を簡略化することができる。
(Test sample preparation process)
The method of the present invention may comprise a step of preparing a test sample by a gene amplification reaction using the same container as that used for the hybridization step prior to the hybridization step. By using the same container, the hybridization step can be performed by introducing the array into the container used for amplification. In addition, by doing this, the number of containers to be used can be reduced and the operation can be simplified.
 遺伝子増幅反応としては、公知の各種の反応が利用でき、例えば、各種手法によるPCRのほか、LCR、SDA、ICAN等が挙げられる。また、被験試料中のポリヌクレオチドを標識するのにあたっては、所定の標識結合性物質が連結されたdNTPを取り込ませる方法によることができる。標識結合性物質とは、ジゴキニゲニン(DIG)などのハプテン(一次シグナル)などが挙げられる。この場合には、当該ハプテン特異的認識抗体を用い、さらに当該認識抗体に付与した例えば、ペルオキシダーゼ等の発色性物質(二次シグナル)を検出シグナルとして用いることができる。 As the gene amplification reaction, various known reactions can be used. Examples include PCR by various methods, LCR, SDA, ICAN, and the like. In addition, the polynucleotide in the test sample can be labeled by a method of incorporating dNTP linked with a predetermined label-binding substance. Examples of the label-binding substance include haptens (primary signal) such as digokigenin (DIG). In this case, the hapten-specific recognition antibody can be used, and a chromogenic substance (secondary signal) such as peroxidase imparted to the recognition antibody can be used as a detection signal.
 遺伝子増幅反応実施後、同一容器内の遺伝子増幅反応液又はハイブリダイゼーション用の液を供給することが好ましい。そして、さらに、ハイブリダイゼーションに先立つ高温による変性工程も同一容器内でそのまま実施することがより好ましい。こうすることで、操作を簡略化し、さらに操作の迅速化、温度制御の迅速化及び高精度化も実現できる。 It is preferable to supply a gene amplification reaction solution or a hybridization solution in the same container after the gene amplification reaction. Further, it is more preferable to carry out the denaturation step at a high temperature prior to the hybridization in the same container. By doing so, it is possible to simplify the operation, further speeding up the operation, speeding up the temperature control and increasing the accuracy.
(シグナル付与工程)
 シグナル付与工程は、ハイブリダイゼーション工程で得られた二重鎖ハイブリダイズ産物に肉眼で視認可能な検出シグナルを付与する工程とすることができる。肉眼で視認可能なシグナルを付与することで、特別な検出装置を要することなく、しかもリアルタイムに発色を肉眼で観察し判定することができる。二重鎖ハイブリダイズ産物にシグナル付与するには、例えば、既に記載のとおり、予め被験試料中のポリヌクレオチドに対してハプテンなどのほか、ビオチンなどの一次シグナルを付与しておくことが挙げられる。そして、本工程において、当該一次シグナルに特異的な二次シグナルを付与することで、当該二次シグナルを利用して肉眼で視認可能な検出シグナルを付与することができる。すなわち、検出系としては、抗原抗体反応やビオチン-アビジン反応を利用できる。
(Signal giving process)
The signal imparting step can be a step of imparting a detection signal visible to the naked eye to the double-stranded hybridized product obtained in the hybridization step. By giving a signal that can be visually recognized by the naked eye, it is possible to observe and determine the color development with the naked eye in real time without requiring a special detection device. In order to give a signal to the double-stranded hybridized product, for example, as already described, a primary signal such as biotin in addition to a hapten is previously given to a polynucleotide in a test sample. In this step, by giving a specific secondary signal to the primary signal, a detection signal that can be visually recognized by the naked eye can be given using the secondary signal. That is, an antigen-antibody reaction or a biotin-avidin reaction can be used as a detection system.
 二次シグナルを利用して肉眼で視認可能な検出シグナルを得るには、二次シグナルが発色性の生成物を生成する酵素であることが好ましい。こうすることで、酵素反応を利用して発色性生成物を速やかにかつリアルタイムに検出することができる。この場合、二次シグナルは、ハプテンに特異手的に結合する抗体とこうした酵素とを備えた複合体とすることができる。 In order to obtain a detection signal that can be visually recognized using the secondary signal, the secondary signal is preferably an enzyme that produces a chromogenic product. By doing so, it is possible to detect the chromogenic product promptly and in real time using an enzyme reaction. In this case, the secondary signal can be a complex comprising an antibody that specifically binds to the hapten and such an enzyme.
 二次シグナルは、こうした酵素を必ずしも備えておらず、単にハプテンなどの一次シグナルに結合する抗体としてもよい。この場合、二次シグナルたる抗体に特異的に結合する二次抗体と酵素との複合体を三次シグナルとして用いればよい。こうした複数シグナルによる検出には、ELISAやビオチン-アビジンシステムにおける周知の手法を用いることができる。 The secondary signal does not necessarily include such an enzyme, and may simply be an antibody that binds to a primary signal such as a hapten. In this case, a complex of a secondary antibody and an enzyme that specifically binds to the antibody that is the secondary signal may be used as the tertiary signal. For detection by such multiple signals, a well-known technique in ELISA or biotin-avidin system can be used.
 シグナル付与工程は、ハイブリダイゼーション工程で用いたのと同一容器内で実施することが好ましい。こうすることで、操作を簡略化して迅速性を向上させることができる。また、アレイを、同一容器に残しておくことで、アレイの容器への投入時(ハイブリダイゼーション工程時)の一定の方向性を容易に維持できる。例えば、過剰試料除去後のアレイが残留した同一容器に、二次シグナルを含む溶液を投入して標識反応を実施することができる。過剰の二次シグナルを除去洗浄後、二次シグナルをそのまま肉眼で視認できる場合以外は、さらに、二次シグナルを発色させる発色反応を実施する。例えば、二次シグナルとしてペルオキシダーゼなどの酵素を用いた場合には、過剰なペルオキシダーゼ除去後に、基質を供給して酵素反応を生じさせる。三次シグナルを要する場合には、洗浄及び反応工程をさらに実施する。 The signal imparting step is preferably performed in the same container used in the hybridization step. By doing so, the operation can be simplified and the speed can be improved. Further, by leaving the array in the same container, it is possible to easily maintain a certain directionality when the array is put into the container (in the hybridization step). For example, the labeling reaction can be carried out by introducing a solution containing a secondary signal into the same container in which the array after removal of the excess sample remains. Except for the case where the secondary signal can be visually recognized with the naked eye after washing after removing the excessive secondary signal, a color reaction for developing the secondary signal is further performed. For example, when an enzyme such as peroxidase is used as the secondary signal, after removing the excess peroxidase, a substrate is supplied to cause an enzyme reaction. If a tertiary signal is required, additional washing and reaction steps are performed.
(検出工程)
 検出工程は、シグナル付与工程で二重鎖ハイブリダイズ産物に付与した検出シグナルに基づいて標的ポリヌクレオチドを検出する工程とすることができる。上記のとおり、二重鎖ハイブリダイズ産物は、検出シグナルが付与されているので、これを肉眼にて観察し、標的ポリヌクレオチドの有無を検出する。
(Detection process)
The detection step can be a step of detecting the target polynucleotide based on the detection signal imparted to the double-stranded hybridization product in the signal imparting step. As described above, since the detection signal is imparted to the double-stranded hybridization product, this is observed with the naked eye to detect the presence or absence of the target polynucleotide.
 検出にあたっては、アレイが充填されたままの容器内で行ってもよいし、アレイを容器から取り出して容器外で行ってもよい。また、シグナル付与のための液が投入されたままの状態で行っても良い。シグナル付与工程において、ハイブリダイゼーション工程に用いたのと同一容器でアレイの方向性が維持された状態とすることで、アレイにおける検出シグナルの検出の際に、投入時と同様である、所定の方向性でシグナルを検出できるため、標的ポリヌクレオチドの検出が容易であり確度も高いものとなる。 Detecting may be performed in a container filled with the array, or may be performed outside the container after the array is taken out of the container. Moreover, you may carry out in the state in which the liquid for signal provision is thrown in. In the signal application step, the same orientation as that used at the time of detection is detected when detecting the detection signal in the array by maintaining the orientation of the array in the same container as that used in the hybridization step. Therefore, the target polynucleotide can be easily detected and the accuracy is high.
 アレイが、発色見本領域を備えるとき、この色調や濃淡と対比観察することで、迅速かつ確度の高い検出が可能となる。また、アレイが、検出シグナルの色調又は濃淡の上限及び下限に相当する2つの発色見本領域を少なくとも備える場合には、上限及び下限を指標として、前記標的ポリヌクレオチドを検出する工程とすることができる。こうすることで、熟練程度や反応誤差によらないで確度の高い検出が可能となる。 When the array has a color sample area, it is possible to detect the color tone and the contrast in a quick and highly accurate manner by observing the color tone and the contrast. In addition, when the array includes at least two color development sample regions corresponding to the upper and lower limits of the color tone or shading of the detection signal, it can be a step of detecting the target polynucleotide using the upper limit and the lower limit as an index. . In this way, highly accurate detection is possible without depending on skill level or reaction error.
 検出工程は、検出対象や用途に応じて、被験試料中の複数の標的ポリヌクレオチドの組み合わせを検出する工程であってもよい。例えば、肺炎の原因菌の型判別のように、複数の遺伝子の複数の配列を検出する場合には、複数の標的ポリヌクレオチドに対応する複数の固定化領域の組み合わせが検出される。この場合、こうした組み合わせを、アレイ上において得られた記固定化領域の発色パターンと、その組み合わせに対応するオリゴヌクレオチドプローブの発色パターン見本と対比して検出するとしてもよい。こうした発色パターン見本は予め準備しておく。例えば、検出しようとするパターン毎に準備しておくことで、迅速かつ容易に確度の高い判別が可能となる。 The detection step may be a step of detecting a combination of a plurality of target polynucleotides in the test sample according to the detection target and application. For example, in the case of detecting a plurality of sequences of a plurality of genes as in the type determination of causative bacteria of pneumonia, a combination of a plurality of immobilization regions corresponding to a plurality of target polynucleotides is detected. In this case, such a combination may be detected by comparing the coloring pattern of the immobilization region obtained on the array with the coloring pattern sample of the oligonucleotide probe corresponding to the combination. Such a color pattern sample is prepared in advance. For example, by preparing for each pattern to be detected, it is possible to quickly and easily determine with high accuracy.
 なお、ハイブリダイゼーション工程及びシグナル付与工程を、同一容器内で行うことが好ましいとしたが、これに限定するものではなく、異なる容器で実施してもよい。また、被験試料調製工程も同様である。例えば、工程毎あるいはさらに細かいステップ毎に、異なる容器に予め適切な液を準備して配置しておき、アレイがこうした容器を反応工程に応じて移動する構成としてもよい。 Although the hybridization step and the signal imparting step are preferably performed in the same container, the present invention is not limited to this and may be performed in different containers. The test sample preparation process is the same. For example, an appropriate liquid may be prepared and arranged in different containers in advance for each process or for each finer step, and the array may be moved according to the reaction process.
(アレイ及びアレイシート)
 本発明によれば、また、本発明方法に用いるアレイが提供される。上記した各種態様のアレイも本発明に含まれる。さらに、本発明によれば、こうしたアレイをアレイ領域として複数個備えるアレイシートも提供される。すなわち、標的ポリヌクレオチドを検出するためのアレイのシートであって、標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を含むアレイ領域を、このアレイ領域毎に分離可能に複数個備えたアレイシートが提供される。このシートによれば、本発明方法に用いられるアレイを簡単に製造、供給できる。アレイ領域毎に分離可能とするには、例えば、上記した好ましい固相担体を用いれば、一般的に使用されるカッターやはさみ等で切断が可能である。あるいは、切断可能に脆弱な部位をアレイ領域間に設けることで、容易に手操作によって、アレイ領域を分離可能である。
(Array and array sheet)
The present invention also provides an array for use in the method of the present invention. The array of the various aspects described above is also included in the present invention. Furthermore, according to the present invention, an array sheet including a plurality of such arrays as an array region is also provided. That is, an array sheet for detecting a target polynucleotide, and a plurality of array regions including a plurality of immobilized regions of oligonucleotide probes previously associated with the target polynucleotide are separable for each array region. An individual array sheet is provided. According to this sheet, the array used in the method of the present invention can be easily manufactured and supplied. In order to be separable for each array region, for example, when the above-described preferred solid support is used, cutting can be performed with a commonly used cutter or scissors. Alternatively, the array region can be easily separated by manual operation by providing a fragile portion that can be cut between the array regions.
 以下、本発明を実施例を挙げて具体的に説明するが、以下の実施例は本発明を説明するものであって、本発明の範囲を限定するものではない。 Hereinafter, the present invention will be specifically described by way of examples. However, the following examples illustrate the present invention and do not limit the scope of the present invention.
(アレイの作製)
 アルデヒド基で表面修飾したポリエーテルスルホン製であって、サイズが285mm×50mm、孔径が0.5μm、厚さが0.15μmのシートに、以下の表に示す塩基配列からなるDNAプローブ溶液を、特開2003-75305号公報に記載されている吐出ユニット(インクジェット法)を用いた日本ガイシ株式会社GENESHOT(登録商標)スポッターを用いて、スポットし、以下の手順で固定化した。
(Production of array)
A DNA probe solution consisting of a base sequence shown in the following table is made on a sheet made of polyethersulfone modified with an aldehyde group and having a size of 285 mm × 50 mm, a pore diameter of 0.5 μm, and a thickness of 0.15 μm. Spotting was performed using a GENSHOT (registered trademark) spotter using a discharge unit (inkjet method) described in Japanese Patent Application Laid-Open No. 2003-75305, and the spot was fixed by the following procedure.
(DNAプローブ溶液)
 オリゴDNAを44種類合成し、Tris-EDTA bufferで溶解した水溶液を、SSC緩衝液、ブロモフェノールブルーと混合してDNAプローブ濃度が2μM~60μMのDNAプローブ溶液を調製した。
(DNA probe solution)
Forty-four oligo DNAs synthesized and dissolved in Tris-EDTA buffer were mixed with SSC buffer and bromophenol blue to prepare a DNA probe solution having a DNA probe concentration of 2 to 60 μM.
Figure JPOXMLDOC01-appb-T000001
 
Figure JPOXMLDOC01-appb-T000001
 
(手順1)
 吐出ユニット内に配置した液体注入部に、DNAプローブ溶液を注入し、シートにスポットする前に、検査用のシート上に検査スポットを行った。品質の検査は、検査スポットに対し、スポットが形成されないことはないか、スポットがいびつな形状ではないか、スポット径が設計値から10% 以上ずれていないか、サテライトと呼ばれる本スポット以外の不要なスポットが発生していないか、スポット位置がスポット径の3分の1以上ずれていないかという項目を実施した。シートの色は白色で、DNAプローブ溶液はブロモフェノールブルーによって青色に着色されているため、目視で検査を実施した。ブロモフェノールブルーは、ハイブリダイゼーション~酵素付抗体免疫反応~酵素発色色素沈着において、溶出し、除去される。
(Procedure 1)
Before injecting the DNA probe solution into the liquid injection portion arranged in the discharge unit and spotting it on the sheet, an inspection spot was formed on the inspection sheet. For quality inspection, no spot is formed on the inspection spot, the spot is not distorted, the spot diameter is not deviated by more than 10% from the design value, or other than this spot called satellite is unnecessary The items of whether a spot was not generated or whether the spot position was shifted by more than one third of the spot diameter were implemented. Since the color of the sheet was white and the DNA probe solution was colored blue with bromophenol blue, the inspection was performed visually. Bromophenol blue is eluted and removed in hybridization, antibody-immune reaction with enzyme, and enzyme coloring pigmentation.
(手順2)
 検査スポットで不良が検出されたときは、吐出ユニット内に配置された圧電/電歪素子の駆動信号を調整して検査スポットを再度行う。駆動信号の調整は電圧値、所定電圧までの上昇時間、所定電圧値のキープ時間、電圧立ち下げ時間の変更で行った。それでも不良が検出されるときは、真空吸引することで吐出ユニットからDNAプローブ溶液を抜き取り、液体注入部にDNAプローブを再度注入して、検査スポットを行う。不良スポットが検出されなくなるまで、この操作を繰り返した。
(Procedure 2)
When a defect is detected at the inspection spot, the inspection spot is performed again by adjusting the drive signal of the piezoelectric / electrostrictive element arranged in the ejection unit. The drive signal was adjusted by changing the voltage value, the rising time to the predetermined voltage, the keeping time of the predetermined voltage value, and the voltage falling time. If a defect is still detected, the DNA probe solution is extracted from the discharge unit by vacuum suction, the DNA probe is injected again into the liquid injection section, and an inspection spot is performed. This operation was repeated until no defective spot was detected.
(手順3)
 不良スポットが検出されなくなったことを確認したのち、以下の方法でオリゴヌクレオチドプローブを図1に示すようにシートにプロットした。すなわち、1種類のDNAプローブにつき、スポットのピッチを横方向(X方向)、縦方向(Y方向)ともに0.05mmで、横方向、縦方向ともに9箇所スポットを行い、横方向0.5mm、縦方向0.5mmのスクエア形状の一つの固定化領域を形成した。固定化領域のコーナーはR=0.05mmとなった。さらに、シート上を吐出ユニットが、シート長手方向(X方向)に移動しながら、シートがシート短手方向(Y方向)に移動して、非接触でスポットを行った。スクエアのピッチを縦方向、横方向ともに0.6mmで5列×10行の格子エリア内に47種類のDNAプローブ溶液から47個の固定化領域を形成・配置して、複数の固定化領域からなる1つの区画(5.9mm×2.9mm)を形成した。さらにこの区画を、縦方向13.5mmピッチ、横方向6.8mmピッチで、1シートに120個形成した。
(Procedure 3)
After confirming that no defective spots were detected, oligonucleotide probes were plotted on a sheet as shown in FIG. 1 by the following method. That is, for one type of DNA probe, the spot pitch is 0.05 mm in both the horizontal direction (X direction) and the vertical direction (Y direction), and nine spots are formed in both the horizontal direction and the vertical direction, and 0.5 mm in the horizontal direction. One immobilization area having a square shape of 0.5 mm in the vertical direction was formed. The corner of the immobilization region was R = 0.05 mm. Further, while the discharge unit moved on the sheet in the longitudinal direction (X direction) of the sheet, the sheet moved in the lateral direction (Y direction) of the sheet, and spotted without contact. 47 immobilization regions were formed and arranged from 47 types of DNA probe solutions in a 5 × 10 grid area with a square pitch of 0.6 mm in both the vertical and horizontal directions, and a plurality of immobilization regions were formed. One section (5.9 mm × 2.9 mm) was formed. Furthermore, 120 sections were formed on one sheet at a pitch of 13.5 mm in the vertical direction and a pitch of 6.8 mm in the horizontal direction.
(手順4)
 複数の顔料系インクを混合して、検出シグナルの発色と同じ色調になるように、発色見本のスポットに使用する溶液を得た。さらに濃淡も検出シグナルの発色と同じになるように、先に得た溶液の2倍希釈、3倍希釈、4倍希釈を行った。これら3種類の溶液を、それぞれ、(手順1)~(手順3)の方法で、各区画の上部の中央に3個隣接してスポットを行い、シート上に各区画毎に発色見本領域を形成した。
(Procedure 4)
A plurality of pigment-based inks were mixed to obtain a solution to be used for the spot of the color development sample so that the color tone was the same as that of the detection signal. Further, the solution obtained previously was diluted 2 times, 3 times, or 4 times so that the color density of the detection signal was the same as that of the detection signal. These three kinds of solutions are spotted in the center of the upper part of each section by using the method of (Procedure 1) to (Procedure 3) to form a color sample area for each section on the sheet. did.
(手順5)
 各アレイの固体識別を可能にするために、発色見本領域の上部に、顔料系マゼンダインクを用いて、ID番号として、“A01・・・・A12、B01・・・・J12”のスポットを行った。
(Procedure 5)
In order to enable identification of each array, a spot of “A01... A12, B01... J12” is performed as an ID number using a pigment-based magenta ink at the top of the color sample area. It was.
(手順6)
 DNAプローブ溶液、発色見本、ID番号のスポットが完了したのち、風乾することで、
DNAプローブ溶液の固定、発色見本及びID番号の固着を行った。
(Procedure 6)
After the DNA probe solution, color sample, and ID number spot are completed,
The DNA probe solution was fixed, the color sample and the ID number were fixed.
(手順7)
(手順1)で行う検査と同様の項目で検査を行った。
(Procedure 7)
The inspection was performed using the same items as the inspection performed in (Procedure 1).
(手順8)
 不良が検出されなかったシートについて、1アレイを4mm×9mmサイズ(アスペクト比:2.25)に、ローラーカッターで切断することで、1シートから120個のアレイを得た。
(Procedure 8)
About the sheet | seat in which the defect was not detected, 1 array was cut | disconnected with the roller cutter to 4 mm x 9 mm size (aspect ratio: 2.25), and 120 arrays were obtained from 1 sheet.
 本実施例では、結核菌の4つの型(BGCワクチン株、北京ファミリー、LAM9、EAI2)を判別への本アレイの適用を評価した。これらの4つの菌型に予め他の方法で判別されている検体から常法に従い、ゲノム抽出サンプルを調製し、このサンプルを、以下の工程で、実施例1で作製したアレイに適用した。図2に工程の概要を示す。 In this example, the application of this array to discriminate four types of Mycobacterium tuberculosis (BGC vaccine strain, Beijing family, LAM9, EAI2) was evaluated. A genome extraction sample was prepared according to a conventional method from specimens that were previously discriminated by these four types of fungi, and this sample was applied to the array prepared in Example 1 in the following steps. FIG. 2 shows an outline of the process.
(遺伝子増幅工程)
 4種類のゲノム抽出サンプルを、エッペンドルフチューブにとり、DR配列認識プライマーを用いるとともに、DIGラベルNTP(PCR DIGラベリングミックス、ロッシュ製)を用いて常法によりPCRを実施して増幅産物溶液を得た。
(Gene amplification process)
Four types of genome extraction samples were taken in an Eppendorf tube, and using a DR sequence recognition primer, PCR was performed by a conventional method using DIG label NTP (PCR DIG labeling mix, manufactured by Roche) to obtain an amplification product solution.
(変性工程)
 各チューブに、ハイブリダイゼーション液として、0.5%Tween20、1%BSAのPBS溶液200μlを加えて、良く混合し、95℃に加熱したヒートブロックに5分配置後、氷水中に移して急冷した。
(Modification process)
To each tube, 200 μl of 0.5% Tween 20, 1% BSA in PBS as a hybridization solution was added, mixed well, placed in a heat block heated to 95 ° C. for 5 minutes, then transferred to ice water and quenched. .
(ハイブリダイゼーション工程)
 各チューブに、実施例1で作製したアレイを一個づつ、発色見本領域が上方となるように投入して、60℃に制御したヒートブロックに挿入して15分ハイブリダイゼーションを実施した。
(Hybridization process)
Each of the arrays prepared in Example 1 was put into each tube so that the color sample area was on top, and inserted into a heat block controlled at 60 ° C., and hybridization was carried out for 15 minutes.
(洗浄工程)
 ハイブリダイゼーション工程に用いた溶液を一旦除去し、チューブ内のアレイに対して新たにハイブリダイゼーション溶液200μlを添加し、60℃のヒートブロックで1分間静置状態で加熱してハイブリダイゼーション液を除去した後、さらに同様にしてハイブリダイゼーション液を交換してそれぞれ10分及び1分の洗浄を繰り返した。
(Washing process)
The solution used in the hybridization step was once removed, 200 μl of hybridization solution was newly added to the array in the tube, and the hybridization solution was removed by heating in a heat block at 60 ° C. for 1 minute. Thereafter, the hybridization solution was changed in the same manner, and washing was repeated for 10 minutes and 1 minute, respectively.
(シグナル付与工程)
 抗DIG抗体酵素(ペルオキシダーゼ)含有試薬(DIG-POD、ロッシュ製)の1000倍希釈液200μlを各チューブ内のアレイに供給して、抗原抗体反応により酵素を結合させた。
(Signal giving process)
200 μl of a 1000-fold diluted solution of an anti-DIG antibody enzyme (peroxidase) -containing reagent (DIG-POD, manufactured by Roche) was supplied to the array in each tube, and the enzyme was bound by an antigen-antibody reaction.
(洗浄工程)
 シグナル付与工程に用いた溶液を除去し、チューブ内のアレイに対して新たにハイブリダイゼーション溶液250μlを添加し、60℃のヒートブロックで1分間静置状態で加熱してハイブリダイゼーション液を除去した後、さらに同様にしてハイブリダイゼーション液を交換してそれぞれ10分及び1分の洗浄を繰り返した。
(Washing process)
After removing the solution used in the signal imparting step, adding 250 μl of hybridization solution to the array in the tube and heating it in a stationary state for 1 minute in a heat block at 60 ° C. to remove the hybridization solution Further, in the same manner, the hybridization solution was changed, and washing was repeated for 10 minutes and 1 minute, respectively.
(基質反応工程)
 洗浄後のチューブに対してペルオキシダーゼの基質溶液(Vec.Lab製、TMBキット)200μlを供給して、室温で酵素反応を行い、青色の反応生成物を生成させた。
(Substrate reaction process)
200 μl of peroxidase substrate solution (manufactured by Vec. Lab, TMB kit) was supplied to the washed tube, and an enzyme reaction was performed at room temperature to produce a blue reaction product.
(検出工程)
 各チューブ内の反応液中で固定化領域の発色パターンを確認したところ、それぞれのチューブのアレイから、結核菌の4種の型、BGCワクチン株、北京ファミリー、LAM9、EAI2をそれぞれ確認できた。これらの4種の型を確認するにあたって、発色見本領域を参照することで容易に個々の固定化領域の検出シグナルが標的ポリヌクレオチドの存在を肯定できるかどうかを簡易にかつ迅速に判断することができた。また、アレイのアスペクト比が約2であり、幅4mm×長さ9mmであったため、チューブ内に収まりやすくかつ方向性を維持して各操作を行うことができた。さらに、複数個の固定化領域がスクエア状であり、かつ、よこ5列×たて10列で整列されて、アスペクト比が約2であったので、複数個の固定化領域の検出シグナルを組み合わせて得られるパターンの判別が容易であり、結核菌の4つの型を迅速に判断することができた。
(Detection process)
When the color development pattern of the immobilization region was confirmed in the reaction solution in each tube, four types of Mycobacterium tuberculosis, BGC vaccine strain, Beijing family, LAM9, and EAI2 could be confirmed from each tube array. In confirming these four types, it is possible to easily and quickly determine whether the detection signal of each immobilization region can affirm the presence of the target polynucleotide by referring to the color development sample region. did it. Further, since the aspect ratio of the array was about 2, and the width was 4 mm × the length was 9 mm, each operation could be easily performed while maintaining the directionality. Furthermore, since the plurality of immobilization regions are square-shaped and aligned in 5 rows × 10 columns, and the aspect ratio is about 2, the detection signals of the plural immobilization regions are combined. Thus, it was easy to discriminate the patterns obtained, and the four types of Mycobacterium tuberculosis could be quickly determined.
配列番号1~44:プローブ SEQ ID NOs: 1-44: Probe

Claims (21)

  1.  標的ポリヌクレオチドの検出方法であって、
     標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域を固相担体上に備えるアレイ上の前記オリゴヌクレオチドプローブと、被験試料とにつき、ハイブリダイゼーションを実施する工程と、
     前記ハイブリダイゼーションで得られた二重鎖ハイブリダイズ産物に肉眼で視認可能な検出シグナルを付与する工程と、
     前記固定化領域から得られる検出シグナルに基づいて標的ポリヌクレオチドを検出する工程と、
    を備え、
     前記ハイブリダイゼーション工程は、前記アレイを用いて、前記アレイ毎に1ml以下の液中でハイブリダイゼーションを実施する工程とする、検出方法。
    A method for detecting a target polynucleotide, comprising:
    Performing hybridization on the test sample and the oligonucleotide probe on the array comprising a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide on a solid phase carrier; and
    Providing a double-stranded hybridization product obtained by the hybridization with a detection signal that can be visually recognized by the naked eye;
    Detecting a target polynucleotide based on a detection signal obtained from the immobilized region;
    With
    The detection method, wherein the hybridization step is a step of performing hybridization in a solution of 1 ml or less for each array using the array.
  2.  前記ハイブリダイゼーション工程は、前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記固相担体が、平面積が150mm2以下、アスペクト比が1.5以上のシート状体である前記アレイを用いて、ハイブリダイゼーションを実施する工程とする、請求項1に記載の検出方法。 In the hybridization step, the immobilization region has a size of 0.2 mm 2 or more and 150 mm 2 or less, and the solid phase carrier has a planar area of 150 mm 2 or less and an aspect ratio of 1.5 or more. The detection method according to claim 1, wherein hybridization is performed using the array.
  3.  前記ハイブリダイゼーション工程は、前記固相担体が、平面積が50mm2以下のシート状体である前記アレイを用いて、前記アレイ毎に0.3ml以下の液中でハイブリダイゼーションを実施する工程とする、請求項1又は2に記載の検出方法。 The hybridization step is a step of performing hybridization in a solution of 0.3 ml or less for each array using the array in which the solid phase carrier is a sheet-like body having a plane area of 50 mm 2 or less. The detection method according to claim 1 or 2.
  4.  前記アスペクト比が20以下である、請求項1~3のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 3, wherein the aspect ratio is 20 or less.
  5.  前記アレイは、前記固相担体上に前記検出シグナルによる発色見本領域を別途備える、請求項1~4のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 4, wherein the array is separately provided with a color development sample region by the detection signal on the solid phase carrier.
  6.  前記発色見本領域は、顔料系インクにより形成されている、請求項5に記載の検出方法。 The detection method according to claim 5, wherein the color sample area is formed of a pigment-based ink.
  7.  前記アレイは、検出シグナルの色調又は濃淡につき程度の異なる2種以上の前記発色見本領域を備える、請求項5又は6に記載の検出方法。 The detection method according to claim 5 or 6, wherein the array includes two or more kinds of the color sample regions having different degrees of color tone or shading of a detection signal.
  8.  前記アレイは、検出シグナルの色調又は濃淡の上限及び下限に相当する2つの前記発色見本領域を少なくとも備えており、
     前記検出工程は、前記上限及び下限を指標として、前記標的ポリヌクレオチドを検出する工程とする、請求項7に記載の検出方法。
    The array includes at least two color sample regions corresponding to the upper limit and the lower limit of the color tone or shading of the detection signal,
    The detection method according to claim 7, wherein the detection step is a step of detecting the target polynucleotide using the upper limit and the lower limit as indices.
  9.  前記固相担体は、液体の浸透性又は透過性を有する、請求項1~8のいずれかに記載の検出方法。 9. The detection method according to claim 1, wherein the solid phase carrier has liquid permeability or permeability.
  10.  前記固相担体は、ポリエーテルスルホン、ニトロセルロース、ナイロン、ポリフッ化ビニリデン及びろ紙から選択される、請求項9に記載の検出方法。 The detection method according to claim 9, wherein the solid phase carrier is selected from polyethersulfone, nitrocellulose, nylon, polyvinylidene fluoride, and filter paper.
  11.  前記固相担体の厚みは、0.01mm以上0.3mm以下である、請求項1~10のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 10, wherein the thickness of the solid phase carrier is 0.01 mm or more and 0.3 mm or less.
  12.  前記アレイは、前記複数個の固定化領域の外縁の所定の一部にハンドリング部位を備える、請求項1~11のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 11, wherein the array includes a handling portion at a predetermined part of an outer edge of the plurality of immobilization regions.
  13.  前記ハイブリダイゼーション工程及び前記シグナル付与工程を、前記アレイを所定の方向性で同一のチューブ状容器に投入した状態を維持して実施する、請求項1~12のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 12, wherein the hybridization step and the signal imparting step are performed while maintaining the state in which the array is put in the same tube-like container with a predetermined direction.
  14.  さらに、前記検出工程を、前記アレイを所定の方向性で前記容器に投入した状態を維持して実施する、請求項13に記載の検出方法。 Furthermore, the detection method according to claim 13, wherein the detection step is performed while maintaining the state where the array is put into the container with a predetermined direction.
  15.  前記ハイブリダイゼーション工程に先立って、前記容器内で遺伝子増幅反応により被験試料を調製する工程を備える、請求項13又は14に記載の検出方法。 The detection method according to claim 13 or 14, further comprising a step of preparing a test sample by a gene amplification reaction in the container prior to the hybridization step.
  16.  前記検出工程は、所定の複数の前記固定化領域から得られる検出シグナルの組み合わせに基づいて複数の前記標的ポリヌクレオチドを検出する工程である、請求項1~15のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 15, wherein the detection step is a step of detecting a plurality of the target polynucleotides based on a combination of detection signals obtained from a predetermined plurality of the immobilized regions.
  17.  前記検出工程は、前記組み合わせを、前記アレイ上において得られた前記固定化領域の発色パターンと、前記組み合わせに対応する前記オリゴヌクレオチドプローブの発色パターン見本と対比して検出する工程である、請求項16に記載の検出方法。 The detection step is a step of detecting the combination in comparison with a coloring pattern of the immobilized region obtained on the array and a coloring pattern sample of the oligonucleotide probe corresponding to the combination. 16. The detection method according to 16.
  18.  前記固定化領域は、2個以上200個以下である、請求項1~17のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 17, wherein the number of the immobilized regions is 2 or more and 200 or less.
  19.  前記オリゴヌクレオチドプローブは、正規直交配列である塩基配列を有するプローブである、請求項1~18のいずれかに記載の検出方法。 The detection method according to any one of claims 1 to 18, wherein the oligonucleotide probe is a probe having a base sequence which is a normal orthogonal sequence.
  20.  請求項1~19のいずれかに記載の検出方法に用いるアレイであって、
     標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域と、肉眼で視認可能な検出シグナルによる発色を提示する発色見本領域と、を固相担体上に備え、
     前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記固相担体が、平面積が150mm2以下、アスペクト比が1.5以上20以下のシート状体である、アレイ。
    An array used in the detection method according to any one of claims 1 to 19,
    A plurality of immobilization regions of oligonucleotide probes pre-associated with the target polynucleotide and a color sample region that presents color development by a detection signal that can be visually recognized by the naked eye are provided on a solid phase carrier.
    The size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, and the solid phase carrier is a sheet-like body having a plane area of 150 mm 2 or less and an aspect ratio of 1.5 or more and 20 or less. .
  21.  標的ポリヌクレオチドを検出するためのアレイのシートであって、
     標的ポリヌクレオチドと予め関連付けられたオリゴヌクレオチドプローブの複数個の固定化領域と、肉眼で視認可能な検出シグナルによる発色を提示する発色見本領域と、有するアレイ領域を複数個固相担体上に備えており、
     前記固定化領域の大きさは、0.2mm2以上150mm2以下であり、前記アレイ領域が、平面積が150mm2以下、アスペクト比が1.5以上20以下であり、
     前記固相担体は、前記アレイ領域毎に分離可能である、シート。
    An array sheet for detecting a target polynucleotide comprising:
    Provided with a plurality of immobilized regions of oligonucleotide probes pre-associated with the target polynucleotide, a color sample region that presents color development by a detection signal visible to the naked eye, and a plurality of array regions on a solid phase carrier And
    The size of the immobilization region is 0.2 mm 2 or more and 150 mm 2 or less, the array region has a plane area of 150 mm 2 or less, and an aspect ratio of 1.5 or more and 20 or less,
    The solid phase carrier is a sheet that is separable for each array region.
PCT/JP2012/066167 2011-06-28 2012-06-25 Array and method for detecting target polynucleotide WO2013002185A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011-143441 2011-06-28
JP2011143441A JP2014176296A (en) 2011-06-28 2011-06-28 Method for detecting target polynucleotide and array

Publications (1)

Publication Number Publication Date
WO2013002185A1 true WO2013002185A1 (en) 2013-01-03

Family

ID=47424077

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/066167 WO2013002185A1 (en) 2011-06-28 2012-06-25 Array and method for detecting target polynucleotide

Country Status (2)

Country Link
JP (1) JP2014176296A (en)
WO (1) WO2013002185A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6412191B2 (en) * 2016-09-21 2018-10-24 クレド バイオメディカル ピーティーイー リミテッド Two-stage nucleic acid reaction detector tube

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521829A (en) * 2004-02-11 2007-08-09 ヘルス プロテクション エージェンシー TB resistance assay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521829A (en) * 2004-02-11 2007-08-09 ヘルス プロテクション エージェンシー TB resistance assay

Also Published As

Publication number Publication date
JP2014176296A (en) 2014-09-25

Similar Documents

Publication Publication Date Title
JP6001374B2 (en) Target nucleic acid detection method and kit used therefor
JP6875998B2 (en) Spatial mapping of molecular profiles of biological tissue samples
CN107810277B (en) High resolution systems, kits, devices, and methods for high throughput microbiological applications
US10677793B2 (en) High resolution systems, kits, apparatus, and methods using lateral flow for high throughput microbiology applications
US8673595B2 (en) Sample analysis method and assay kit used therein
TWI280282B (en) Microarray method of genotyping multiple samples at multiple loci
US5641658A (en) Method for performing amplification of nucleic acid with two primers bound to a single solid support
US20180023045A1 (en) High resolution systems, kits, apparatus, and methods using combinatorial media strategies for high throughput microbiology applications
US9752183B2 (en) Multiplexed digital PCR
JP4972104B2 (en) Oligonucleotide microarray for pathogen identification
CN110049817B (en) Method of transferring material from a first microfabricated device to a second microfabricated device, and kit therefor
EP1457573B1 (en) Method for integrated nucleic acid integrity assessment and analysis
CN108179177A (en) A kind of kit and detection method of quick detection nucleic acid mutation
US20200263227A1 (en) High resolution systems, kits, apparatus, and methods using magnetic beads for high throughput microbiology applications
WO2013002185A1 (en) Array and method for detecting target polynucleotide
JP5918981B2 (en) Agent for detecting target polynucleotide and use thereof
JP6202455B2 (en) Target nucleic acid detection method
WO2018005389A1 (en) High resolution systems, kits, apparatus, and methods using combinatorial media strategies for high throughput microbiology applications
EP3478650B1 (en) Methods using lateral flow for high throughput microbiology applications
TWI287581B (en) Method for biochip detection of cell nucleotide
JP5240814B2 (en) Method for detecting common DNA fragments
JP2012200223A (en) Method for quantitatively determining nucleic acid
TW201416454A (en) Oligonucleotide probe and biochip for identifying mycobacteria and the identification method thereof
WO2010043418A2 (en) Integrated amplification, processing and analysis of biomolecules in a microfluidic reaction medium

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12803804

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12803804

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP